Visible node/edge number:
Node colors:
Node labels:

show label of nodes with degree >=

Node sizes:
Edge colors:
Edge widths factor:
Layout:

gravity >=

edgeLength =

GRN in network:

Notice: IE browser need to manually refresh (F5) this page after resetting the network.

This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.

"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.

miRNA-gene regulations

(Download full result)

Num microRNA           Gene miRNA log2FC miRNA pvalue Gene log2FC Gene pvalue Interaction Correlation beta Correlation P-value PMID Reported in cancer studies
1 hsa-miR-342-3p AADAC 1.22 0 -4.47 0 miRanda -0.67 0 NA
2 hsa-miR-361-5p AAK1 -0.1 0.09543 -0.32 0 PITA -0.21 0 NA
3 hsa-miR-590-3p AASS 1.27 0 -1.98 0 MirTarget; miRanda -0.38 0 NA
4 hsa-miR-27a-5p ABAT -1.24 0 0.64 0.00201 miRNATAP -0.31 0 NA
5 hsa-miR-590-3p ABAT 1.27 0 0.64 0.00201 PITA; miRanda -0.47 0 NA
6 hsa-miR-361-5p ABCA1 -0.1 0.09543 -1.41 0 miRanda; mirMAP -0.27 4.0E-5 NA
7 hsa-miR-454-3p ABCA1 1.28 0 -1.41 0 miRNATAP -0.15 0 NA
8 hsa-miR-590-3p ABCA1 1.27 0 -1.41 0 miRanda -0.16 0 NA
9 hsa-miR-590-3p ABCA10 1.27 0 -4.63 0 miRanda; mirMAP -0.81 0 NA
10 hsa-miR-342-3p ABCA13 1.22 0 -1.78 0 miRanda -0.5 0 NA
11 hsa-miR-432-5p ABCA3 -1.28 0 0.75 0 MirTarget -0.19 0 NA
12 hsa-miR-590-3p ABCA5 1.27 0 -1.92 0 MirTarget; miRanda; mirMAP -0.21 0 NA
13 hsa-miR-342-3p ABCA6 1.22 0 -3.37 0 miRanda -0.3 0 NA
14 hsa-miR-590-3p ABCA6 1.27 0 -3.37 0 MirTarget; miRanda -0.59 0 NA
15 hsa-miR-590-3p ABCA8 1.27 0 -5.12 0 miRanda -1.07 0 NA
16 hsa-miR-590-3p ABCA9 1.27 0 -4.44 0 miRanda -0.76 0 NA
17 hsa-miR-590-3p ABCB1 1.27 0 -2.55 0 miRanda -0.41 0 NA
18 hsa-miR-361-5p ABCB10 -0.1 0.09543 0.24 0.00025 MirTarget; miRanda -0.16 4.0E-5 NA
19 hsa-miR-590-3p ABCB5 1.27 0 -4.85 0 miRanda; mirMAP -0.91 0 NA
20 hsa-miR-590-3p ABCC13 1.27 0 2.29 0 miRanda -0.27 0.01292 NA
21 hsa-miR-590-3p ABCC3 1.27 0 -0.09 0.58506 mirMAP -0.19 3.0E-5 NA
22 hsa-miR-664a-3p ABCC4 -0.24 0.01971 -0.06 0.70716 mirMAP -0.31 0 NA
23 hsa-miR-432-5p ABCC5 -1.28 0 0.8 0 MirTarget -0.1 0.00065 NA
24 hsa-miR-590-3p ABCC6P1 1.27 0 -2.44 0 miRanda -0.48 0 NA
25 hsa-miR-342-3p ABCC9 1.22 0 -2.42 0 miRanda -0.26 0 NA
26 hsa-miR-590-3p ABCC9 1.27 0 -2.42 0 miRanda; mirMAP -0.37 0 NA
27 hsa-miR-590-3p ABCD2 1.27 0 -4.13 0 MirTarget; miRanda; mirMAP -0.25 0.00039 NA
28 hsa-miR-369-3p ABCD3 0.09 0.4852 0.36 0.0002 MirTarget; PITA; miRNATAP -0.16 0 NA
29 hsa-miR-590-3p ABCG2 1.27 0 -1.95 0 miRanda; mirMAP -0.51 0 NA
30 hsa-miR-410-3p ABHD10 -0.62 4.0E-5 0.03 0.59624 MirTarget -0.11 0 NA
31 hsa-miR-590-3p ABHD12B 1.27 0 -0.34 0.2539 miRanda; mirMAP; miRNATAP -0.33 6.0E-5 NA
32 hsa-miR-590-3p ABHD15 1.27 0 -0.6 0 miRanda -0.13 0 NA
33 hsa-miR-214-3p ABHD2 -0.52 0.00021 0.45 0.00053 miRNATAP -0.12 0.00013 NA
34 hsa-miR-361-5p ABHD2 -0.1 0.09543 0.45 0.00053 PITA; mirMAP -0.59 0 NA
35 hsa-miR-432-5p ABHD2 -1.28 0 0.45 0.00053 mirMAP -0.1 0.00105 NA
36 hsa-miR-590-3p ABHD2 1.27 0 0.45 0.00053 miRanda; mirMAP -0.15 2.0E-5 NA
37 hsa-miR-590-3p ABI3BP 1.27 0 -2.67 0 miRanda -0.44 0 NA
38 hsa-miR-361-5p ABL2 -0.1 0.09543 0.21 0.00092 mirMAP -0.16 2.0E-5 NA
39 hsa-miR-590-3p ABLIM1 1.27 0 -1.69 0 miRanda; mirMAP -0.13 5.0E-5 NA
40 hsa-miR-590-3p ACAD11 1.27 0 -1.05 0 miRanda; mirMAP -0.14 0 NA
41 hsa-miR-590-3p ACADL 1.27 0 -5.19 0 miRanda -0.63 0 NA
42 hsa-miR-24-2-5p ACADSB -0.22 0.05957 -0.52 0.002 MirTarget -0.41 0 NA
43 hsa-miR-361-5p ACADSB -0.1 0.09543 -0.52 0.002 MirTarget; miRanda; miRNATAP -0.46 0 NA
44 hsa-miR-590-3p ACADSB 1.27 0 -0.52 0.002 MirTarget; miRanda; mirMAP -0.44 0 NA
45 hsa-miR-664a-3p ACAN -0.24 0.01971 2.73 0 mirMAP -0.32 3.0E-5 NA
46 hsa-miR-181d-5p ACAP2 0.78 0 -0.39 0 MirTarget -0.11 0 NA
47 hsa-miR-361-5p ACAP2 -0.1 0.09543 -0.39 0 miRanda; mirMAP; miRNATAP -0.2 0 NA
48 hsa-miR-532-3p ACBD4 -0.4 0.00687 -0.42 0.00049 miRNATAP -0.3 0 NA
49 hsa-miR-361-5p ACBD5 -0.1 0.09543 0.06 0.42369 miRanda -0.24 0 NA
50 hsa-miR-181d-5p ACER3 0.78 0 -0.64 0 MirTarget -0.24 0 NA
51 hsa-miR-342-3p ACER3 1.22 0 -0.64 0 miRanda -0.1 0.00023 NA
52 hsa-miR-361-5p ACER3 -0.1 0.09543 -0.64 0 mirMAP -0.24 0.0002 NA
53 hsa-miR-214-3p ACLY -0.52 0.00021 0.43 0 MirTarget -0.13 0 NA
54 hsa-miR-361-5p ACLY -0.1 0.09543 0.43 0 miRNAWalker2 validate; miRanda -0.29 0 NA
55 hsa-miR-590-3p ACOT1 1.27 0 -0.54 0 miRanda -0.22 0 NA
56 hsa-miR-590-3p ACOT2 1.27 0 -0.5 0 miRanda -0.21 0 NA
57 hsa-miR-590-3p ACOX2 1.27 0 -0.76 0.001 miRanda -0.51 0 NA
58 hsa-miR-181d-5p ACSL1 0.78 0 -2.41 0 MirTarget -0.43 0 NA
59 hsa-miR-454-3p ACSL1 1.28 0 -2.41 0 MirTarget -0.18 0 NA
60 hsa-miR-590-3p ACSL1 1.27 0 -2.41 0 miRanda -0.15 0.00096 NA
61 hsa-miR-342-3p ACSL4 1.22 0 -1.48 0 MirTarget; miRanda -0.26 0 NA
62 hsa-miR-454-3p ACSL4 1.28 0 -1.48 0 MirTarget; miRNATAP -0.16 0 NA
63 hsa-miR-664a-3p ACSL4 -0.24 0.01971 -1.48 0 mirMAP -0.15 0.00026 NA
64 hsa-miR-590-3p ACSM5 1.27 0 -3.68 0 miRanda -0.6 0 NA
65 hsa-miR-181d-5p ACSS3 0.78 0 -1.68 0 MirTarget -0.24 0 NA
66 hsa-miR-590-3p ACSS3 1.27 0 -1.68 0 miRanda -0.38 0 NA
67 hsa-miR-590-3p ACTC1 1.27 0 -1.25 0 miRanda -0.14 0.04278 NA
68 hsa-miR-590-3p ACTG2 1.27 0 -3.41 0 miRanda -0.32 4.0E-5 NA
69 hsa-miR-26a-2-3p ACTN2 -0.14 0.17854 0.57 0.06176 mirMAP -0.21 0.03349 NA
70 hsa-miR-432-5p ACTR3C -1.28 0 0.17 0.10546 mirMAP -0.12 1.0E-5 NA
71 hsa-miR-590-3p ACVR1 1.27 0 -0.46 0 miRanda -0.11 0 NA
72 hsa-miR-532-3p ACVR1B -0.4 0.00687 0.15 0.02139 PITA; miRNATAP -0.11 0 NA
73 hsa-miR-590-3p ACVR1C 1.27 0 -5.2 0 miRanda -0.58 0 NA
74 hsa-miR-454-3p ACVR2A 1.28 0 -0.96 0 miRNATAP -0.14 0 NA
75 hsa-miR-590-3p ACVR2A 1.27 0 -0.96 0 MirTarget; PITA; miRanda; miRNATAP -0.13 0 NA
76 hsa-miR-342-3p ACVRL1 1.22 0 -0.99 0 miRanda -0.16 0 NA
77 hsa-miR-361-5p ADAL -0.1 0.09543 -0.36 0 miRanda -0.16 0.00036 NA
78 hsa-miR-361-5p ADAM10 -0.1 0.09543 -0.37 0.00057 miRanda -0.51 0 NA
79 hsa-miR-361-5p ADAM12 -0.1 0.09543 1.3 0 miRanda -0.54 0 NA
80 hsa-miR-361-5p ADAM19 -0.1 0.09543 1.6 0 miRanda -0.25 0.0017 NA
81 hsa-miR-664a-3p ADAM19 -0.24 0.01971 1.6 0 MirTarget -0.36 0 NA
82 hsa-miR-361-5p ADAM22 -0.1 0.09543 -1.22 0 mirMAP -0.33 0.0048 NA
83 hsa-miR-454-3p ADAM22 1.28 0 -1.22 0 mirMAP -0.25 0 NA
84 hsa-miR-590-3p ADAM22 1.27 0 -1.22 0 MirTarget; PITA; miRanda; mirMAP -0.35 0 NA
85 hsa-miR-590-3p ADAM23 1.27 0 -0.63 0.00091 miRanda -0.28 0 NA
86 hsa-miR-590-3p ADAM33 1.27 0 -3.44 0 miRanda -0.86 0 NA
87 hsa-miR-342-3p ADAM9 1.22 0 -0.03 0.77501 miRanda -0.14 0 NA
88 hsa-miR-342-3p ADAMTS1 1.22 0 -2.52 0 miRanda -0.41 0 NA
89 hsa-miR-590-3p ADAMTS1 1.27 0 -2.52 0 miRanda -0.3 0 NA
90 hsa-miR-362-5p ADAMTS12 -0.25 0.07261 0.1 0.62063 mirMAP -0.35 0 NA
91 hsa-miR-532-3p ADAMTS13 -0.4 0.00687 0.49 0.00058 miRNATAP -0.3 0 NA
92 hsa-miR-590-3p ADAMTS16 1.27 0 -0.28 0.29506 miRanda; mirMAP -0.57 0 NA
93 hsa-miR-362-5p ADAMTS17 -0.25 0.07261 0.43 0.0095 mirMAP -0.12 0.00451 NA
94 hsa-miR-454-3p ADAMTS18 1.28 0 -2.9 0 miRNATAP -0.45 0 NA
95 hsa-miR-590-3p ADAMTS18 1.27 0 -2.9 0 PITA; miRanda; miRNATAP -0.55 0 NA
96 hsa-miR-590-3p ADAMTS19 1.27 0 0.71 0.02881 PITA; miRanda; mirMAP; miRNATAP -0.31 0.00066 NA
97 hsa-miR-590-3p ADAMTS5 1.27 0 -3.55 0 PITA; miRanda; miRNATAP -0.48 0 NA
98 hsa-miR-664a-3p ADAMTS6 -0.24 0.01971 1.1 0 mirMAP -0.21 0 NA
99 hsa-miR-143-5p ADAMTS8 -1.09 0 -1.48 0 MirTarget -0.14 0.0026 NA
100 hsa-miR-590-3p ADAMTS8 1.27 0 -1.48 0 miRanda -0.4 0 NA
101 hsa-miR-590-3p ADAMTS9 1.27 0 -1.55 0 miRanda -0.15 9.0E-5 NA
102 hsa-miR-590-3p ADAMTSL1 1.27 0 -1.1 0 miRanda; mirMAP -0.26 0 NA
103 hsa-miR-590-3p ADAMTSL3 1.27 0 -1.39 0 miRanda -0.23 0 NA
104 hsa-miR-590-3p ADAMTSL5 1.27 0 0.43 0.02335 miRanda -0.38 0 NA
105 hsa-miR-342-3p ADARB1 1.22 0 -0.6 0 miRanda -0.13 0 NA
106 hsa-miR-590-3p ADARB2 1.27 0 -1.08 1.0E-5 miRanda -0.21 0.0013 NA
107 hsa-miR-214-3p ADCY1 -0.52 0.00021 -0.05 0.84149 mirMAP -0.12 0.03717 NA
108 hsa-miR-369-3p ADCY1 0.09 0.4852 -0.05 0.84149 PITA; miRNATAP -0.17 0.01028 NA
109 hsa-miR-454-3p ADCY1 1.28 0 -0.05 0.84149 MirTarget; miRNATAP -0.19 0.00127 NA
110 hsa-miR-342-3p ADCY2 1.22 0 -0.73 0.00385 miRanda -0.39 0 NA
111 hsa-miR-454-3p ADCY2 1.28 0 -0.73 0.00385 miRNATAP -0.33 0 NA
112 hsa-miR-590-3p ADCY2 1.27 0 -0.73 0.00385 mirMAP -0.23 0.00088 NA
113 hsa-miR-342-3p ADCY3 1.22 0 -0.58 0 miRanda -0.14 0 NA
114 hsa-miR-532-3p ADCY6 -0.4 0.00687 -0.63 0 PITA -0.17 0 NA
115 hsa-miR-590-3p ADCY6 1.27 0 -0.63 0 miRanda -0.26 0 NA
116 hsa-miR-361-5p ADCY9 -0.1 0.09543 0.12 0.23839 miRanda -0.25 2.0E-5 NA
117 hsa-miR-590-3p ADCY9 1.27 0 0.12 0.23839 miRanda -0.22 0 NA
118 hsa-miR-590-3p ADCYAP1 1.27 0 -0.67 0.02162 MirTarget; PITA; miRanda; miRNATAP -0.3 0.0002 NA
119 hsa-miR-664a-3p ADCYAP1 -0.24 0.01971 -0.67 0.02162 MirTarget -0.24 0.01529 NA
120 hsa-miR-362-5p ADCYAP1R1 -0.25 0.07261 -4.27 0 MirTarget; TargetScan -0.16 0.01761 NA
121 hsa-miR-590-3p ADD1 1.27 0 -0.47 0 MirTarget; PITA; miRanda; miRNATAP -0.15 0 NA
122 hsa-miR-590-3p ADD3 1.27 0 -1.66 0 MirTarget; PITA; miRanda; mirMAP -0.12 0.00108 NA
123 hsa-miR-664a-3p ADD3 -0.24 0.01971 -1.66 0 MirTarget -0.11 0.01192 NA
124 hsa-miR-590-3p ADH1A 1.27 0 -6.13 0 miRanda -0.94 0 NA
125 hsa-miR-342-3p ADH1B 1.22 0 -7.23 0 miRanda -0.54 2.0E-5 NA
126 hsa-miR-590-3p ADH1B 1.27 0 -7.23 0 miRanda; mirMAP -1.26 0 NA
127 hsa-miR-590-3p ADH1C 1.27 0 -5.26 0 miRanda -0.93 0 NA
128 hsa-miR-590-3p ADH4 1.27 0 -4.75 0 miRanda; mirMAP -0.53 0 NA
129 hsa-miR-342-3p ADI1 1.22 0 -0.35 3.0E-5 miRanda -0.14 0 NA
130 hsa-miR-590-3p ADIPOQ 1.27 0 -7.2 0 PITA; miRanda; mirMAP -1.2 0 NA
131 hsa-miR-181d-5p ADM 0.78 0 -1.96 0 MirTarget -0.17 0.00048 NA
132 hsa-miR-214-3p ADM2 -0.52 0.00021 2.41 0 mirMAP -0.2 0 NA
133 hsa-miR-432-5p ADM2 -1.28 0 2.41 0 mirMAP -0.26 0 NA
134 hsa-miR-361-5p ADNP -0.1 0.09543 0.29 6.0E-5 miRanda -0.31 0 NA
135 hsa-miR-342-3p ADORA2B 1.22 0 -0.76 0 miRanda -0.34 0 NA
136 hsa-miR-342-3p ADRA1A 1.22 0 -4.75 0 miRanda -0.46 0 NA
137 hsa-miR-342-3p ADRA2B 1.22 0 -1.36 0 miRanda -0.24 0 NA
138 hsa-miR-342-3p ADRB1 1.22 0 -2.83 0 PITA; miRanda -0.29 2.0E-5 NA
139 hsa-miR-590-3p ADRB1 1.27 0 -2.83 0 PITA; miRanda; mirMAP; miRNATAP -0.4 0 NA
140 hsa-miR-590-3p ADRB2 1.27 0 -3.09 0 MirTarget; PITA; miRanda -0.47 0 NA
141 hsa-miR-361-5p ADSS -0.1 0.09543 0.81 0 miRanda -0.2 0 NA
142 hsa-miR-362-5p AFAP1 -0.25 0.07261 -0.21 0.00289 mirMAP -0.1 0 NA
143 hsa-miR-664a-3p AFAP1 -0.24 0.01971 -0.21 0.00289 mirMAP -0.11 0 NA
144 hsa-miR-590-3p AFAP1L2 1.27 0 -1.15 0 miRanda; mirMAP -0.33 0 NA
145 hsa-miR-454-3p AFF1 1.28 0 -0.82 0 MirTarget -0.14 0 NA
146 hsa-miR-590-3p AFF1 1.27 0 -0.82 0 MirTarget; PITA; miRanda; miRNATAP -0.21 0 NA
147 hsa-miR-342-3p AFF2 1.22 0 -1.78 0 mirMAP -0.32 0 NA
148 hsa-miR-590-3p AFF2 1.27 0 -1.78 0 PITA; miRanda; mirMAP; miRNATAP -0.17 0.00099 NA
149 hsa-miR-664a-3p AFF2 -0.24 0.01971 -1.78 0 mirMAP -0.19 0.0026 NA
150 hsa-miR-369-3p AFF3 0.09 0.4852 -0.33 0.2554 MirTarget; PITA; miRNATAP -0.29 0.00018 NA

Over-represented Gene Ontology Biological Process

NumGOOverlapSizeP ValueAdj. P Value
1 NEUROGENESIS 498 1402 2.201e-41 3.675e-38
2 CARDIOVASCULAR SYSTEM DEVELOPMENT 325 788 2.37e-41 3.675e-38
3 CIRCULATORY SYSTEM DEVELOPMENT 325 788 2.37e-41 3.675e-38
4 TISSUE DEVELOPMENT 514 1518 2.695e-36 3.135e-33
5 REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT 552 1672 1.263e-35 1.176e-32
6 CELL DEVELOPMENT 485 1426 9.983e-35 7.742e-32
7 REGULATION OF CELL DIFFERENTIATION 494 1492 4.26e-32 2.832e-29
8 VASCULATURE DEVELOPMENT 207 469 2.579e-31 1.5e-28
9 REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS 365 1021 8.489e-31 4.389e-28
10 ORGAN MORPHOGENESIS 314 841 2.503e-30 1.164e-27
11 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 460 1395 2.188e-29 9.256e-27
12 POSITIVE REGULATION OF DEVELOPMENTAL PROCESS 393 1142 3.196e-29 1.239e-26
13 BLOOD VESSEL MORPHOGENESIS 168 364 2.468e-28 8.834e-26
14 RESPONSE TO ENDOGENOUS STIMULUS 469 1450 7.729e-28 2.569e-25
15 CELLULAR COMPONENT MORPHOGENESIS 322 900 2.883e-27 8.944e-25
16 LOCOMOTION 377 1114 1.915e-26 5.57e-24
17 ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS 335 957 2.07e-26 5.666e-24
18 MOVEMENT OF CELL OR SUBCELLULAR COMPONENT 417 1275 8.342e-26 2.157e-23
19 BIOLOGICAL ADHESION 352 1032 2.142e-25 5.246e-23
20 REGULATION OF CELL DEVELOPMENT 298 836 5.607e-25 1.305e-22
21 NEURON DIFFERENTIATION 308 874 7.34e-25 1.626e-22
22 SKELETAL SYSTEM DEVELOPMENT 189 455 8.991e-25 1.902e-22
23 REGULATION OF NEURON DIFFERENTIATION 218 554 1.129e-24 2.137e-22
24 CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 206 513 1.148e-24 2.137e-22
25 CELL PROJECTION ORGANIZATION 315 902 1.146e-24 2.137e-22
26 POSITIVE REGULATION OF CELL COMMUNICATION 478 1532 1.589e-24 2.844e-22
27 CELLULAR RESPONSE TO ENDOGENOUS STIMULUS 341 1008 6.444e-24 1.111e-21
28 REGULATION OF CELLULAR COMPONENT MOVEMENT 277 771 7.497e-24 1.246e-21
29 ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY 254 689 9.724e-24 1.56e-21
30 CENTRAL NERVOUS SYSTEM DEVELOPMENT 304 872 1.084e-23 1.681e-21
31 REGULATION OF NERVOUS SYSTEM DEVELOPMENT 270 750 2.044e-23 3.069e-21
32 HEART DEVELOPMENT 189 466 2.578e-23 3.749e-21
33 REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 504 1656 3.134e-23 4.419e-21
34 POSITIVE REGULATION OF MOLECULAR FUNCTION 535 1791 1.161e-22 1.588e-20
35 EPITHELIUM DEVELOPMENT 319 945 3.065e-22 4.074e-20
36 REGULATION OF TRANSPORT 536 1804 3.884e-22 5.02e-20
37 EMBRYO DEVELOPMENT 305 894 4.307e-22 5.417e-20
38 REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 530 1784 7.125e-22 8.724e-20
39 REGULATION OF CELL MORPHOGENESIS 209 552 2.687e-21 3.206e-19
40 POSITIVE REGULATION OF CELL DIFFERENTIATION 283 823 4.114e-21 4.786e-19
41 UROGENITAL SYSTEM DEVELOPMENT 133 299 6.608e-21 7.5e-19
42 CELL MOTILITY 285 835 1.003e-20 1.086e-18
43 LOCALIZATION OF CELL 285 835 1.003e-20 1.086e-18
44 NEURON DEVELOPMENT 245 687 1.039e-20 1.098e-18
45 TUBE DEVELOPMENT 207 552 1.57e-20 1.623e-18
46 TISSUE MORPHOGENESIS 201 533 2.72e-20 2.752e-18
47 EMBRYONIC MORPHOGENESIS 202 539 5.016e-20 4.966e-18
48 REGULATION OF NEURON PROJECTION DEVELOPMENT 164 408 6.331e-20 6.137e-18
49 REGULATION OF PHOSPHORUS METABOLIC PROCESS 481 1618 6.737e-20 6.397e-18
50 SENSORY ORGAN DEVELOPMENT 188 493 1.158e-19 1.078e-17
51 POSITIVE REGULATION OF GENE EXPRESSION 508 1733 1.204e-19 1.098e-17
52 NEGATIVE REGULATION OF CELL COMMUNICATION 373 1192 2.081e-19 1.862e-17
53 NEURON PROJECTION DEVELOPMENT 202 545 2.157e-19 1.894e-17
54 POSITIVE REGULATION OF CELL DEVELOPMENT 181 472 2.848e-19 2.454e-17
55 CELL PART MORPHOGENESIS 226 633 2.984e-19 2.524e-17
56 REGULATION OF CELL PROLIFERATION 448 1496 3.486e-19 2.897e-17
57 REGULATION OF CELL PROJECTION ORGANIZATION 205 558 3.7e-19 3.021e-17
58 NEGATIVE REGULATION OF RESPONSE TO STIMULUS 414 1360 4.146e-19 3.326e-17
59 HEAD DEVELOPMENT 246 709 4.951e-19 3.905e-17
60 POSITIVE REGULATION OF NEURON DIFFERENTIATION 131 306 7.165e-19 5.557e-17
61 NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS 270 801 7.527e-19 5.742e-17
62 BEHAVIOR 192 516 1.059e-18 7.946e-17
63 ANGIOGENESIS 126 293 2.144e-18 1.583e-16
64 POSITIVE REGULATION OF CATALYTIC ACTIVITY 450 1518 2.226e-18 1.618e-16
65 REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 139 337 3.154e-18 2.257e-16
66 RESPONSE TO OXYGEN CONTAINING COMPOUND 415 1381 4.438e-18 3.129e-16
67 POSITIVE REGULATION OF BIOSYNTHETIC PROCESS 518 1805 5.26e-18 3.653e-16
68 SINGLE ORGANISM BEHAVIOR 152 384 7.76e-18 5.31e-16
69 NEURON PROJECTION MORPHOGENESIS 157 402 9.73e-18 6.561e-16
70 POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 167 437 1.044e-17 6.859e-16
71 CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION 147 368 1.047e-17 6.859e-16
72 INTRACELLULAR SIGNAL TRANSDUCTION 460 1572 1.198e-17 7.741e-16
73 CONNECTIVE TISSUE DEVELOPMENT 93 194 1.29e-17 8.222e-16
74 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 318 1004 1.77e-17 1.113e-15
75 POSITIVE REGULATION OF RESPONSE TO STIMULUS 545 1929 1.93e-17 1.182e-15
76 REGULATION OF MEMBRANE POTENTIAL 139 343 1.922e-17 1.182e-15
77 RESPONSE TO LIPID 288 888 1.977e-17 1.195e-15
78 POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 354 1152 4.225e-17 2.508e-15
79 CELLULAR RESPONSE TO ORGANIC SUBSTANCE 524 1848 4.258e-17 2.508e-15
80 RESPONSE TO HORMONE 288 893 4.591e-17 2.67e-15
81 POSITIVE REGULATION OF TRANSPORT 298 936 9.032e-17 5.159e-15
82 NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 310 983 9.092e-17 5.159e-15
83 REGULATION OF PROTEIN MODIFICATION PROCESS 489 1710 1.077e-16 6.035e-15
84 RESPONSE TO GROWTH FACTOR 175 475 1.143e-16 6.331e-15
85 POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 321 1036 3.951e-16 2.138e-14
86 POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 321 1036 3.951e-16 2.138e-14
87 POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION 124 303 4.284e-16 2.291e-14
88 GROWTH 155 410 4.826e-16 2.523e-14
89 NEGATIVE REGULATION OF CELL PROLIFERATION 219 643 4.807e-16 2.523e-14
90 POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT 102 232 6.168e-16 3.189e-14
91 EAR DEVELOPMENT 90 195 8.399e-16 4.294e-14
92 CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND 259 799 9.606e-16 4.82e-14
93 REGULATION OF GTPASE ACTIVITY 226 673 9.633e-16 4.82e-14
94 EMBRYONIC ORGAN DEVELOPMENT 153 406 1.031e-15 5.106e-14
95 RESPONSE TO ORGANIC CYCLIC COMPOUND 289 917 1.182e-15 5.789e-14
96 REGULATION OF GROWTH 215 633 1.257e-15 6.093e-14
97 POSITIVE REGULATION OF LOCOMOTION 156 420 2.358e-15 1.131e-13
98 REGULATION OF DEVELOPMENTAL GROWTH 118 289 2.689e-15 1.277e-13
99 PROTEIN PHOSPHORYLATION 294 944 3.635e-15 1.709e-13
100 POSITIVE REGULATION OF HYDROLASE ACTIVITY 284 905 3.862e-15 1.797e-13
101 REGULATION OF CELLULAR LOCALIZATION 376 1277 5.872e-15 2.705e-13
102 EMBRYONIC ORGAN MORPHOGENESIS 114 279 7.482e-15 3.413e-13
103 REGULATION OF SYSTEM PROCESS 178 507 1.24e-14 5.601e-13
104 CARTILAGE DEVELOPMENT 72 147 1.44e-14 6.444e-13
105 RESPONSE TO STEROID HORMONE 175 497 1.535e-14 6.8e-13
106 NEGATIVE REGULATION OF CELL DIFFERENTIATION 205 609 1.651e-14 7.246e-13
107 DEVELOPMENTAL GROWTH 129 333 1.68e-14 7.304e-13
108 MORPHOGENESIS OF AN EPITHELIUM 148 400 1.782e-14 7.679e-13
109 TUBE MORPHOGENESIS 125 323 4.669e-14 1.993e-12
110 APPENDAGE DEVELOPMENT 78 169 6.903e-14 2.894e-12
111 LIMB DEVELOPMENT 78 169 6.903e-14 2.894e-12
112 CELL CELL SIGNALING 244 767 7.075e-14 2.939e-12
113 REGULATION OF HYDROLASE ACTIVITY 383 1327 8.037e-14 3.309e-12
114 REGULATION OF KINASE ACTIVITY 246 776 8.564e-14 3.465e-12
115 MUSCLE STRUCTURE DEVELOPMENT 155 432 8.524e-14 3.465e-12
116 RESPONSE TO ABIOTIC STIMULUS 308 1024 1.149e-13 4.608e-12
117 CELLULAR RESPONSE TO HORMONE STIMULUS 187 552 1.239e-13 4.927e-12
118 NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 184 541 1.298e-13 5.077e-12
119 NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 184 541 1.298e-13 5.077e-12
120 CIRCULATORY SYSTEM PROCESS 136 366 1.417e-13 5.493e-12
121 MESENCHYME DEVELOPMENT 84 190 1.533e-13 5.848e-12
122 STEM CELL DIFFERENTIATION 84 190 1.533e-13 5.848e-12
123 REGULATION OF MAPK CASCADE 215 660 1.667e-13 6.308e-12
124 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY 172 498 1.821e-13 6.831e-12
125 REGULATION OF ION TRANSPORT 197 592 1.887e-13 7.025e-12
126 MODULATION OF SYNAPTIC TRANSMISSION 117 301 2.116e-13 7.816e-12
127 POSITIVE REGULATION OF KINASE ACTIVITY 167 482 3.024e-13 1.108e-11
128 POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 269 876 3.523e-13 1.279e-11
129 GLAND DEVELOPMENT 143 395 3.546e-13 1.279e-11
130 NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 234 740 4.738e-13 1.696e-11
131 FOREBRAIN DEVELOPMENT 132 357 4.929e-13 1.751e-11
132 RESPONSE TO NITROGEN COMPOUND 264 859 5.327e-13 1.878e-11
133 REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 88 207 6.221e-13 2.176e-11
134 REGULATION OF OSSIFICATION 79 178 6.276e-13 2.179e-11
135 SKELETAL SYSTEM MORPHOGENESIS 86 201 7.395e-13 2.549e-11
136 REGULATION OF EPITHELIAL CELL PROLIFERATION 111 285 7.491e-13 2.563e-11
137 COGNITION 101 251 7.847e-13 2.665e-11
138 REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 94 229 1.235e-12 4.162e-11
139 POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS 330 1135 1.821e-12 6.094e-11
140 NEGATIVE REGULATION OF PHOSPHORYLATION 148 422 2.376e-12 7.897e-11
141 SENSORY ORGAN MORPHOGENESIS 96 239 3.254e-12 1.074e-10
142 SYNAPSE ORGANIZATION 67 145 3.671e-12 1.203e-10
143 MESENCHYMAL CELL DIFFERENTIATION 63 134 6.252e-12 2.034e-10
144 POSITIVE REGULATION OF DEVELOPMENTAL GROWTH 70 156 6.798e-12 2.197e-10
145 NEURON PROJECTION GUIDANCE 85 205 7.702e-12 2.472e-10
146 REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 64 138 9.065e-12 2.889e-10
147 REGULATION OF BLOOD CIRCULATION 111 295 9.876e-12 3.126e-10
148 PATTERN SPECIFICATION PROCESS 145 418 1.008e-11 3.168e-10
149 REGULATION OF CELL DEATH 407 1472 1.114e-11 3.48e-10
150 CELLULAR RESPONSE TO LIPID 155 457 1.428e-11 4.429e-10
151 EYE DEVELOPMENT 119 326 1.819e-11 5.604e-10
152 CELL CELL ADHESION 194 608 2.062e-11 6.311e-10
153 EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING 180 554 2.085e-11 6.34e-10
154 POSITIVE REGULATION OF CELL PROLIFERATION 246 814 2.294e-11 6.932e-10
155 KIDNEY EPITHELIUM DEVELOPMENT 59 125 2.366e-11 7.102e-10
156 REGULATION OF SECRETION 217 699 2.397e-11 7.15e-10
157 NEURON MIGRATION 54 110 2.461e-11 7.294e-10
158 REGULATION OF CELLULAR COMPONENT BIOGENESIS 234 767 2.615e-11 7.7e-10
159 EPITHELIAL CELL DEVELOPMENT 78 186 2.84e-11 8.311e-10
160 MORPHOGENESIS OF A BRANCHING STRUCTURE 72 167 3.465e-11 1.008e-09
161 REGULATION OF CARTILAGE DEVELOPMENT 37 63 4.05e-11 1.17e-09
162 TAXIS 155 464 5.258e-11 1.51e-09
163 NEGATIVE REGULATION OF GENE EXPRESSION 408 1493 5.9e-11 1.683e-09
164 EAR MORPHOGENESIS 54 112 5.931e-11 1.683e-09
165 HEART MORPHOGENESIS 85 212 6.235e-11 1.758e-09
166 CHEMICAL HOMEOSTASIS 259 874 6.29e-11 1.763e-09
167 REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 104 278 6.539e-11 1.822e-09
168 REGULATION OF CHONDROCYTE DIFFERENTIATION 30 46 6.979e-11 1.933e-09
169 REGULATION OF PHOSPHOLIPASE ACTIVITY 37 64 7.695e-11 2.119e-09
170 EMBRYONIC SKELETAL SYSTEM DEVELOPMENT 57 122 8.494e-11 2.325e-09
171 REGULATION OF INTRACELLULAR TRANSPORT 195 621 8.586e-11 2.336e-09
172 REGULATION OF TRANSMEMBRANE TRANSPORT 144 426 9.909e-11 2.681e-09
173 REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY 90 232 1.385e-10 3.724e-09
174 PHOSPHORYLATION 343 1228 1.497e-10 4.002e-09
175 POSITIVE REGULATION OF ION TRANSPORT 91 236 1.596e-10 4.243e-09
176 REGULATION OF METAL ION TRANSPORT 116 325 1.634e-10 4.319e-09
177 RESPONSE TO WOUNDING 179 563 1.715e-10 4.507e-09
178 RESPONSE TO EXTERNAL STIMULUS 481 1821 2.286e-10 5.976e-09
179 RESPONSE TO MECHANICAL STIMULUS 83 210 2.426e-10 6.307e-09
180 TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 77 190 2.684e-10 6.938e-09
181 POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS 404 1492 2.717e-10 6.985e-09
182 REGULATION OF CELL ADHESION 195 629 2.854e-10 7.296e-09
183 REGULATION OF HOMEOSTATIC PROCESS 148 447 2.919e-10 7.421e-09
184 POSITIVE REGULATION OF MAPK CASCADE 154 470 2.996e-10 7.549e-09
185 TELENCEPHALON DEVELOPMENT 88 228 3.001e-10 7.549e-09
186 POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY 32 53 3.096e-10 7.744e-09
187 DIGESTIVE SYSTEM DEVELOPMENT 64 148 3.6e-10 8.957e-09
188 EPITHELIAL CELL DIFFERENTIATION 160 495 4.199e-10 1.039e-08
189 REGULATION OF DENDRITE DEVELOPMENT 55 120 4.456e-10 1.097e-08
190 CELLULAR RESPONSE TO ACID CHEMICAL 72 175 4.537e-10 1.111e-08
191 RESPONSE TO ACID CHEMICAL 113 319 4.708e-10 1.147e-08
192 POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 68 162 4.917e-10 1.192e-08
193 REGULATION OF CYTOPLASMIC TRANSPORT 156 481 5.291e-10 1.276e-08
194 BONE DEVELOPMENT 66 156 5.909e-10 1.417e-08
195 POSITIVE REGULATION OF GROWTH 90 238 6.519e-10 1.555e-08
196 NEGATIVE REGULATION OF LOCOMOTION 97 263 6.915e-10 1.642e-08
197 REGULATION OF ANATOMICAL STRUCTURE SIZE 153 472 8.086e-10 1.91e-08
198 POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 48 100 8.202e-10 1.928e-08
199 CHONDROCYTE DIFFERENTIATION 34 60 9.381e-10 2.194e-08
200 SYNAPTIC SIGNALING 140 424 1.082e-09 2.505e-08
201 REGULATION OF VASCULATURE DEVELOPMENT 88 233 1.081e-09 2.505e-08
202 NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS 406 1517 1.219e-09 2.807e-08
203 DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS 49 104 1.225e-09 2.807e-08
204 PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS 512 1977 1.276e-09 2.91e-08
205 REGULATION OF PROTEIN LOCALIZATION 271 950 1.588e-09 3.599e-08
206 RESPONSE TO ALCOHOL 123 362 1.593e-09 3.599e-08
207 NEGATIVE REGULATION OF CELL DEATH 252 872 1.639e-09 3.684e-08
208 MEMBRANE DEPOLARIZATION 34 61 1.7e-09 3.791e-08
209 REGULATION OF EPITHELIAL CELL MIGRATION 68 166 1.703e-09 3.791e-08
210 REGULATION OF CELL SUBSTRATE ADHESION 70 173 1.855e-09 4.11e-08
211 RESPONSE TO OXYGEN LEVELS 109 311 1.899e-09 4.187e-08
212 POSITIVE REGULATION OF OSSIFICATION 42 84 1.926e-09 4.228e-08
213 REGULATION OF CHEMOTAXIS 72 180 1.987e-09 4.342e-08
214 REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 151 470 2.079e-09 4.52e-08
215 REGULATION OF ION HOMEOSTASIS 78 201 2.252e-09 4.873e-08
216 REGULATION OF CATION TRANSMEMBRANE TRANSPORT 80 208 2.294e-09 4.941e-08
217 BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE 57 131 2.453e-09 5.26e-08
218 RHYTHMIC PROCESS 105 298 2.685e-09 5.732e-08
219 ION TRANSPORT 344 1262 2.946e-09 6.26e-08
220 HOMEOSTATIC PROCESS 361 1337 3.784e-09 8.002e-08
221 TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 214 724 3.831e-09 8.066e-08
222 CELLULAR RESPONSE TO NITROGEN COMPOUND 159 505 3.874e-09 8.12e-08
223 REGULATION OF HORMONE LEVELS 152 478 4.039e-09 8.408e-08
224 REGULATION OF TRANSFERASE ACTIVITY 268 946 4.048e-09 8.408e-08
225 REGULATION OF HEART CONTRACTION 83 221 4.325e-09 8.945e-08
226 MUSCLE TISSUE DEVELOPMENT 98 275 4.607e-09 9.485e-08
227 MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL 25 39 4.661e-09 9.554e-08
228 INNER EAR MORPHOGENESIS 44 92 4.73e-09 9.652e-08
229 NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 141 437 5.19e-09 1.055e-07
230 MUSCLE CELL DIFFERENTIATION 87 237 6.668e-09 1.349e-07
231 NEURAL CREST CELL DIFFERENTIATION 38 75 6.998e-09 1.41e-07
232 CARDIAC CHAMBER DEVELOPMENT 60 144 7.049e-09 1.412e-07
233 MUSCLE ORGAN DEVELOPMENT 98 277 7.071e-09 1.412e-07
234 POSITIVE REGULATION OF TRANSFERASE ACTIVITY 186 616 7.113e-09 1.414e-07
235 ENDOTHELIUM DEVELOPMENT 43 90 7.33e-09 1.445e-07
236 MESONEPHROS DEVELOPMENT 43 90 7.33e-09 1.445e-07
237 REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC 29 50 7.753e-09 1.522e-07
238 FAT CELL DIFFERENTIATION 48 106 9.135e-09 1.786e-07
239 REGULATION OF MAP KINASE ACTIVITY 109 319 9.434e-09 1.837e-07
240 REGULATION OF RESPONSE TO EXTERNAL STIMULUS 261 926 1.085e-08 2.104e-07
241 NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS 185 616 1.218e-08 2.352e-07
242 MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL 13 14 1.343e-08 2.581e-07
243 NERVE DEVELOPMENT 35 68 1.614e-08 3.091e-07
244 REGULATION OF HEART RATE 41 86 1.761e-08 3.358e-07
245 REGULATION OF LIPASE ACTIVITY 40 83 1.783e-08 3.387e-07
246 CELL SUBSTRATE ADHESION 65 164 1.816e-08 3.435e-07
247 POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 62 154 1.916e-08 3.595e-07
248 REGULATION OF CELL GROWTH 127 391 1.912e-08 3.595e-07
249 CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND 146 465 2.034e-08 3.8e-07
250 REGULATION OF ORGAN MORPHOGENESIS 87 242 2.075e-08 3.862e-07
251 REGULATION OF AXONOGENESIS 66 168 2.133e-08 3.953e-07
252 LEARNING 55 131 2.142e-08 3.955e-07
253 CELL PROJECTION ASSEMBLY 93 264 2.153e-08 3.96e-07
254 RESPONSE TO KETONE 70 182 2.244e-08 4.111e-07
255 NEPHRON DEVELOPMENT 50 115 2.364e-08 4.314e-07
256 POSITIVE REGULATION OF CELL DEATH 181 605 2.381e-08 4.328e-07
257 CARDIOCYTE DIFFERENTIATION 44 96 2.394e-08 4.335e-07
258 EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS 43 93 2.499e-08 4.507e-07
259 POSITIVE REGULATION OF LIPASE ACTIVITY 34 66 2.509e-08 4.508e-07
260 REGULATION OF BODY FLUID LEVELS 156 506 2.612e-08 4.674e-07
261 ADULT BEHAVIOR 56 135 2.665e-08 4.752e-07
262 REGULATION OF CELLULAR RESPONSE TO STRESS 202 691 2.707e-08 4.807e-07
263 NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH 40 84 2.73e-08 4.811e-07
264 NEGATIVE REGULATION OF GROWTH 85 236 2.724e-08 4.811e-07
265 ARTERY DEVELOPMENT 37 75 2.762e-08 4.849e-07
266 REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL 30 55 3.008e-08 5.262e-07
267 OSSIFICATION 89 251 3.028e-08 5.276e-07
268 POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION 46 103 3.13e-08 5.434e-07
269 SECRETION 176 588 3.578e-08 6.189e-07
270 ACTION POTENTIAL 43 94 3.692e-08 6.363e-07
271 REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION 70 184 3.758e-08 6.452e-07
272 HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES 61 153 3.807e-08 6.513e-07
273 SECOND MESSENGER MEDIATED SIGNALING 63 160 3.998e-08 6.814e-07
274 NEGATIVE REGULATION OF TRANSPORT 143 458 4.175e-08 7.074e-07
275 MUSCLE SYSTEM PROCESS 97 282 4.181e-08 7.074e-07
276 ACTIVATION OF PROTEIN KINASE ACTIVITY 96 279 4.81e-08 8.109e-07
277 CELL JUNCTION ORGANIZATION 70 185 4.838e-08 8.127e-07
278 POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT 30 56 5.203e-08 8.709e-07
279 NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION 32 62 6.066e-08 1.008e-06
280 POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 32 62 6.066e-08 1.008e-06
281 ION HOMEOSTASIS 172 576 6.112e-08 1.012e-06
282 CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES 75 204 6.64e-08 1.096e-06
283 CARDIAC MUSCLE CELL DIFFERENTIATION 36 74 6.708e-08 1.103e-06
284 RESPIRATORY SYSTEM DEVELOPMENT 73 197 6.831e-08 1.119e-06
285 REGULATION OF NEUROTRANSMITTER LEVELS 71 190 6.975e-08 1.139e-06
286 CELL GROWTH 55 135 7.373e-08 1.2e-06
287 REGULATION OF OSTEOBLAST DIFFERENTIATION 48 112 7.713e-08 1.251e-06
288 NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 94 274 7.751e-08 1.252e-06
289 EXTRACELLULAR STRUCTURE ORGANIZATION 102 304 7.868e-08 1.267e-06
290 RESPONSE TO DRUG 135 431 8.049e-08 1.291e-06
291 CALCIUM ION TRANSPORT 80 223 8.381e-08 1.34e-06
292 REGULATION OF TRANSPORTER ACTIVITY 73 198 8.66e-08 1.38e-06
293 CYCLIC NUCLEOTIDE MEDIATED SIGNALING 26 46 9.528e-08 1.508e-06
294 EMBRYONIC CRANIAL SKELETON MORPHOGENESIS 26 46 9.528e-08 1.508e-06
295 NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS 294 1087 9.778e-08 1.542e-06
296 PALLIUM DEVELOPMENT 60 153 9.871e-08 1.552e-06
297 METANEPHROS DEVELOPMENT 38 81 9.915e-08 1.553e-06
298 LOCOMOTORY BEHAVIOR 68 181 1.029e-07 1.607e-06
299 REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 36 75 1.035e-07 1.61e-06
300 SYNAPSE ASSEMBLY 34 69 1.038e-07 1.61e-06
301 ENDOTHELIAL CELL DIFFERENTIATION 35 72 1.042e-07 1.611e-06
302 REGULATION OF STEM CELL DIFFERENTIATION 48 113 1.075e-07 1.656e-06
303 MULTICELLULAR ORGANISMAL SIGNALING 51 123 1.114e-07 1.71e-06
304 GLAND MORPHOGENESIS 43 97 1.131e-07 1.731e-06
305 POSITIVE REGULATION OF SYNAPTIC TRANSMISSION 47 110 1.173e-07 1.79e-06
306 RESPONSE TO BMP 42 94 1.206e-07 1.828e-06
307 CELLULAR RESPONSE TO BMP STIMULUS 42 94 1.206e-07 1.828e-06
308 AMEBOIDAL TYPE CELL MIGRATION 60 154 1.295e-07 1.956e-06
309 NEGATIVE REGULATION OF CELL DEVELOPMENT 101 303 1.306e-07 1.967e-06
310 IMMUNE SYSTEM DEVELOPMENT 172 582 1.321e-07 1.983e-06
311 WOUND HEALING 144 470 1.353e-07 2.018e-06
312 REGULATION OF STEM CELL PROLIFERATION 40 88 1.353e-07 2.018e-06
313 SECRETION BY CELL 148 486 1.375e-07 2.038e-06
314 CRANIAL SKELETAL SYSTEM DEVELOPMENT 29 55 1.371e-07 2.038e-06
315 RESPONSE TO TRANSFORMING GROWTH FACTOR BETA 57 144 1.404e-07 2.074e-06
316 REGIONALIZATION 103 311 1.411e-07 2.078e-06
317 INOSITOL LIPID MEDIATED SIGNALING 51 124 1.516e-07 2.225e-06
318 BONE MORPHOGENESIS 37 79 1.536e-07 2.247e-06
319 SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION 127 404 1.547e-07 2.256e-06
320 RESPONSE TO INORGANIC SUBSTANCE 146 479 1.57e-07 2.276e-06
321 REPRODUCTIVE SYSTEM DEVELOPMENT 128 408 1.569e-07 2.276e-06
322 REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 72 197 1.578e-07 2.28e-06
323 POSITIVE REGULATION OF DENDRITE DEVELOPMENT 32 64 1.589e-07 2.29e-06
324 REGULATION OF ENDOTHELIAL CELL PROLIFERATION 43 98 1.615e-07 2.32e-06
325 REGULATION OF CELLULAR PROTEIN LOCALIZATION 164 552 1.774e-07 2.54e-06
326 REGULATION OF PHOSPHOLIPASE C ACTIVITY 23 39 1.815e-07 2.591e-06
327 SIGNAL RELEASE 65 173 1.941e-07 2.762e-06
328 POST EMBRYONIC DEVELOPMENT 40 89 1.971e-07 2.796e-06
329 RESPONSE TO EXTRACELLULAR STIMULUS 136 441 1.977e-07 2.796e-06
330 POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS 127 406 2.097e-07 2.957e-06
331 NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION 28 53 2.131e-07 2.996e-06
332 SMAD PROTEIN SIGNAL TRANSDUCTION 29 56 2.285e-07 3.183e-06
333 REGULATION OF DENDRITIC SPINE DEVELOPMENT 29 56 2.285e-07 3.183e-06
334 ORGANIC ANION TRANSPORT 122 387 2.278e-07 3.183e-06
335 CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS 69 188 2.357e-07 3.274e-06
336 NEGATIVE REGULATION OF KINASE ACTIVITY 86 250 2.38e-07 3.286e-06
337 REGULATION OF BMP SIGNALING PATHWAY 36 77 2.378e-07 3.286e-06
338 CELL MATRIX ADHESION 49 119 2.527e-07 3.468e-06
339 ORGAN GROWTH 33 68 2.52e-07 3.468e-06
340 REGULATION OF CELL MATRIX ADHESION 40 90 2.846e-07 3.894e-06
341 REGULATION OF MUSCLE TISSUE DEVELOPMENT 44 103 2.958e-07 4.036e-06
342 RESPONSE TO ESTROGEN 77 218 3.003e-07 4.08e-06
343 POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 26 48 3.008e-07 4.08e-06
344 REGULATION OF SYNAPTIC PLASTICITY 55 140 3.091e-07 4.156e-06
345 REGULATION OF SYNAPSE ORGANIZATION 47 113 3.09e-07 4.156e-06
346 CARDIAC MUSCLE TISSUE DEVELOPMENT 55 140 3.091e-07 4.156e-06
347 REGULATION OF ACTIN FILAMENT BASED PROCESS 102 312 3.272e-07 4.388e-06
348 ARTERY MORPHOGENESIS 27 51 3.314e-07 4.418e-06
349 NEGATIVE REGULATION OF CHEMOTAXIS 27 51 3.314e-07 4.418e-06
350 NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 48 117 3.802e-07 5.054e-06
351 REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 30 60 3.855e-07 5.11e-06
352 CARDIAC CHAMBER MORPHOGENESIS 44 104 4.111e-07 5.434e-06
353 REGULATION OF EMBRYONIC DEVELOPMENT 47 114 4.215e-07 5.556e-06
354 CELL FATE COMMITMENT 79 227 4.241e-07 5.575e-06
355 DIVALENT INORGANIC CATION TRANSPORT 90 268 4.271e-07 5.598e-06
356 STRIATED MUSCLE CELL DIFFERENTIATION 64 173 4.58e-07 5.986e-06
357 PALATE DEVELOPMENT 38 85 4.663e-07 6.078e-06
358 NEGATIVE REGULATION OF NEURON DIFFERENTIATION 69 191 4.682e-07 6.085e-06
359 ORGANIC ACID TRANSPORT 88 261 4.7e-07 6.091e-06
360 MULTI MULTICELLULAR ORGANISM PROCESS 75 213 4.891e-07 6.322e-06
361 MEMORY 42 98 4.906e-07 6.324e-06
362 KIDNEY MORPHOGENESIS 37 82 4.951e-07 6.364e-06
363 ERBB SIGNALING PATHWAY 36 79 5.226e-07 6.699e-06
364 POSITIVE REGULATION OF POTASSIUM ION TRANSPORT 22 38 5.26e-07 6.724e-06
365 REGULATION OF HORMONE SECRETION 88 262 5.662e-07 7.218e-06
366 POSITIVE REGULATION OF MAP KINASE ACTIVITY 73 207 6.453e-07 8.204e-06
367 CELL JUNCTION ASSEMBLY 51 129 6.527e-07 8.276e-06
368 POSITIVE REGULATION OF VASCULATURE DEVELOPMENT 52 133 7.638e-07 9.657e-06
369 ANION TRANSPORT 150 507 7.714e-07 9.727e-06
370 DEVELOPMENTAL CELL GROWTH 35 77 8.066e-07 1.014e-05
371 NEPHRON EPITHELIUM DEVELOPMENT 40 93 8.137e-07 1.02e-05
372 CELLULAR RESPONSE TO EXTERNAL STIMULUS 88 264 8.172e-07 1.022e-05
373 REGULATION OF CELL SIZE 63 172 8.375e-07 1.045e-05
374 OVULATION CYCLE 46 113 8.579e-07 1.065e-05
375 REGULATION OF MUSCLE ORGAN DEVELOPMENT 43 103 8.585e-07 1.065e-05
376 RESPONSE TO PEPTIDE 124 404 8.858e-07 1.093e-05
377 CELL PROLIFERATION 190 672 8.853e-07 1.093e-05
378 RESPONSE TO CORTICOSTEROID 64 176 9.216e-07 1.134e-05
379 OUTFLOW TRACT MORPHOGENESIS 28 56 9.365e-07 1.15e-05
380 NEGATIVE CHEMOTAXIS 22 39 9.718e-07 1.19e-05
381 REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 118 381 9.784e-07 1.195e-05
382 NEUROTRANSMITTER TRANSPORT 58 155 1.007e-06 1.227e-05
383 POSITIVE REGULATION OF INTRACELLULAR TRANSPORT 115 370 1.101e-06 1.338e-05
384 CALCIUM ION TRANSMEMBRANE TRANSPORT 59 159 1.126e-06 1.364e-05
385 POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT 51 131 1.13e-06 1.365e-05
386 REGULATION OF ENDOTHELIAL CELL MIGRATION 46 114 1.153e-06 1.39e-05
387 RENAL TUBULE DEVELOPMENT 35 78 1.175e-06 1.412e-05
388 POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 94 289 1.197e-06 1.436e-05
389 REGULATION OF MESENCHYMAL CELL PROLIFERATION 20 34 1.225e-06 1.466e-05
390 EXOCRINE SYSTEM DEVELOPMENT 24 45 1.247e-06 1.488e-05
391 CELLULAR RESPONSE TO PEPTIDE 90 274 1.256e-06 1.494e-05
392 REGULATION OF NEURON APOPTOTIC PROCESS 68 192 1.289e-06 1.53e-05
393 REGULATION OF EXTENT OF CELL GROWTH 42 101 1.298e-06 1.537e-05
394 MUSCLE CONTRACTION 79 233 1.383e-06 1.633e-05
395 NEURAL CREST CELL MIGRATION 26 51 1.417e-06 1.667e-05
396 MESODERM MORPHOGENESIS 31 66 1.419e-06 1.667e-05
397 NEGATIVE REGULATION OF SECRETION 70 200 1.487e-06 1.743e-05
398 CARDIAC MUSCLE CELL ACTION POTENTIAL 21 37 1.497e-06 1.746e-05
399 AXON EXTENSION 21 37 1.497e-06 1.746e-05
400 METAL ION TRANSPORT 167 582 1.532e-06 1.782e-05
401 CELLULAR CHEMICAL HOMEOSTASIS 164 570 1.589e-06 1.844e-05
402 CEREBRAL CORTEX DEVELOPMENT 43 105 1.594e-06 1.845e-05
403 GLYCOPROTEIN METABOLIC PROCESS 110 353 1.63e-06 1.882e-05
404 CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT 32 70 2.026e-06 2.334e-05
405 CELLULAR HOMEOSTASIS 189 676 2.104e-06 2.418e-05
406 POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION 31 67 2.121e-06 2.425e-05
407 REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 31 67 2.121e-06 2.425e-05
408 ENDOCRINE SYSTEM DEVELOPMENT 48 123 2.129e-06 2.428e-05
409 DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION 171 602 2.273e-06 2.586e-05
410 EMBRYONIC PATTERN SPECIFICATION 28 58 2.3e-06 2.611e-05
411 FORMATION OF PRIMARY GERM LAYER 44 110 2.577e-06 2.918e-05
412 POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 21 38 2.697e-06 3.046e-05
413 NEGATIVE REGULATION OF CELL GROWTH 61 170 2.72e-06 3.064e-05
414 REGULATION OF DENDRITE MORPHOGENESIS 33 74 2.785e-06 3.13e-05
415 NEGATIVE REGULATION OF CELL MATRIX ADHESION 18 30 2.827e-06 3.162e-05
416 REGULATION OF DENDRITIC SPINE MORPHOGENESIS 18 30 2.827e-06 3.162e-05
417 REGULATION OF CYTOSKELETON ORGANIZATION 146 502 3.08e-06 3.437e-05
418 IN UTERO EMBRYONIC DEVELOPMENT 98 311 3.454e-06 3.845e-05
419 VASCULOGENESIS 28 59 3.521e-06 3.91e-05
420 SMOOTH MUSCLE TISSUE DEVELOPMENT 13 18 3.533e-06 3.914e-05
421 NEGATIVE REGULATION OF CELL ADHESION 75 223 3.544e-06 3.917e-05
422 CAMERA TYPE EYE MORPHOGENESIS 41 101 3.6e-06 3.969e-05
423 SINGLE ORGANISM CELL ADHESION 135 459 3.799e-06 4.17e-05
424 DIVALENT INORGANIC CATION HOMEOSTASIS 106 343 3.8e-06 4.17e-05
425 PROTEIN LOCALIZATION 447 1805 3.944e-06 4.317e-05
426 OVULATION CYCLE PROCESS 37 88 3.984e-06 4.352e-05
427 EYE MORPHOGENESIS 51 136 4.101e-06 4.469e-05
428 NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 85 262 4.25e-06 4.62e-05
429 REGULATION OF CALCIUM ION TRANSPORT 71 209 4.271e-06 4.633e-05
430 ODONTOGENESIS 42 105 4.313e-06 4.667e-05
431 SEX DIFFERENTIATION 86 266 4.366e-06 4.713e-05
432 CRANIAL NERVE MORPHOGENESIS 15 23 4.459e-06 4.792e-05
433 SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 108 352 4.454e-06 4.792e-05
434 POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION 110 360 4.502e-06 4.827e-05
435 COCHLEA DEVELOPMENT 21 39 4.71e-06 5.038e-05
436 REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION 43 109 5.096e-06 5.438e-05
437 AUTONOMIC NERVOUS SYSTEM DEVELOPMENT 22 42 5.116e-06 5.447e-05
438 ORGANIC HYDROXY COMPOUND METABOLIC PROCESS 140 482 5.257e-06 5.574e-05
439 FEMALE SEX DIFFERENTIATION 45 116 5.259e-06 5.574e-05
440 REGULATION OF WNT SIGNALING PATHWAY 97 310 5.391e-06 5.695e-05
441 SPROUTING ANGIOGENESIS 23 45 5.397e-06 5.695e-05
442 DIGESTIVE TRACT MORPHOGENESIS 24 48 5.561e-06 5.854e-05
443 CARDIAC VENTRICLE DEVELOPMENT 42 106 5.732e-06 6.021e-05
444 REGULATION OF JNK CASCADE 57 159 5.872e-06 6.153e-05
445 EMBRYONIC CAMERA TYPE EYE FORMATION 10 12 5.955e-06 6.227e-05
446 VASCULAR PROCESS IN CIRCULATORY SYSTEM 58 163 6.366e-06 6.641e-05
447 NEGATIVE REGULATION OF MAPK CASCADE 53 145 6.442e-06 6.661e-05
448 LIPID TRANSLOCATION 14 21 6.414e-06 6.661e-05
449 NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT 16 26 6.43e-06 6.661e-05
450 TRANSMEMBRANE TRANSPORT 285 1098 6.421e-06 6.661e-05
451 CAMP METABOLIC PROCESS 19 34 6.481e-06 6.686e-05
452 REGULATION OF POTASSIUM ION TRANSPORT 35 83 6.651e-06 6.846e-05
453 POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 93 296 6.922e-06 7.11e-05
454 LIMBIC SYSTEM DEVELOPMENT 40 100 7.224e-06 7.404e-05
455 REGULATION OF ORGANELLE ORGANIZATION 303 1178 7.255e-06 7.419e-05
456 NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT 34 80 7.296e-06 7.445e-05
457 CAMP MEDIATED SIGNALING 20 37 7.339e-06 7.472e-05
458 POSITIVE REGULATION OF STEM CELL PROLIFERATION 28 61 7.892e-06 8.018e-05
459 FORELIMB MORPHOGENESIS 21 40 7.993e-06 8.102e-05
460 RESPONSE TO ESTRADIOL 53 146 8.107e-06 8.193e-05
461 CYTOSKELETON ORGANIZATION 224 838 8.118e-06 8.193e-05
462 CARDIAC MUSCLE CELL CONTRACTION 17 29 8.342e-06 8.383e-05
463 POSITIVE REGULATION OF CARTILAGE DEVELOPMENT 17 29 8.342e-06 8.383e-05
464 ANTERIOR POSTERIOR PATTERN SPECIFICATION 66 194 8.65e-06 8.674e-05
465 REGULATION OF SMOOTH MUSCLE CELL MIGRATION 24 49 8.777e-06 8.783e-05
466 POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION 13 19 9.065e-06 9.052e-05
467 EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS 15 24 9.619e-06 9.584e-05
468 REGULATION OF RESPONSE TO STRESS 368 1468 9.663e-06 9.607e-05
469 SALIVARY GLAND DEVELOPMENT 18 32 1.004e-05 9.963e-05
470 NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 44 115 1.009e-05 9.969e-05
471 REGULATION OF EPITHELIAL CELL DIFFERENTIATION 46 122 1.007e-05 9.969e-05
472 POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 30 68 1.014e-05 1e-04
473 REGULATION OF NEURON DEATH 81 252 1.041e-05 0.0001024
474 REGULATION OF BLOOD PRESSURE 59 169 1.044e-05 0.0001025
475 REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION 68 203 1.148e-05 0.0001124
476 FOREBRAIN CELL MIGRATION 28 62 1.158e-05 0.0001129
477 CARDIAC VENTRICLE MORPHOGENESIS 28 62 1.158e-05 0.0001129
478 NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION 52 144 1.165e-05 0.0001134
479 PROTEIN AUTOPHOSPHORYLATION 65 192 1.206e-05 0.0001172
480 POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 146 514 1.224e-05 0.0001186
481 COLLAGEN FIBRIL ORGANIZATION 20 38 1.25e-05 0.0001205
482 HEART PROCESS 35 85 1.25e-05 0.0001205
483 MESENCHYME MORPHOGENESIS 20 38 1.25e-05 0.0001205
484 NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 40 102 1.268e-05 0.0001219
485 NEGATIVE REGULATION OF AXON GUIDANCE 16 27 1.276e-05 0.0001222
486 POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT 16 27 1.276e-05 0.0001222
487 NEURON PROJECTION EXTENSION 25 53 1.328e-05 0.0001266
488 CYTOSOLIC CALCIUM ION TRANSPORT 25 53 1.328e-05 0.0001266
489 CARDIAC CONDUCTION 34 82 1.386e-05 0.0001319
490 REGULATION OF RESPONSE TO WOUNDING 121 413 1.441e-05 0.0001368
491 POSITIVE REGULATION OF AXONOGENESIS 30 69 1.443e-05 0.0001368
492 REGULATION OF FAT CELL DIFFERENTIATION 41 106 1.47e-05 0.0001389
493 POSITIVE REGULATION OF CHEMOTAXIS 45 120 1.472e-05 0.0001389
494 EPITHELIAL CELL PROLIFERATION 36 89 1.517e-05 0.0001429
495 DENDRITE DEVELOPMENT 33 79 1.533e-05 0.0001438
496 REGULATION OF CELLULAR COMPONENT SIZE 102 337 1.531e-05 0.0001438
497 SMOOTH MUSCLE CELL DIFFERENTIATION 17 30 1.555e-05 0.000145
498 POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION 17 30 1.555e-05 0.000145
499 REGULATION OF HEART RATE BY CARDIAC CONDUCTION 17 30 1.555e-05 0.000145
500 REGULATION OF VASOCONSTRICTION 29 66 1.56e-05 0.0001452
501 NEGATIVE REGULATION OF NEURON DEATH 59 171 1.568e-05 0.0001456
502 GLIOGENESIS 60 175 1.661e-05 0.000154
503 POSITIVE REGULATION OF SECRETION 110 370 1.736e-05 0.0001606
504 NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS 49 135 1.756e-05 0.0001621
505 REGULATION OF SMOOTH MUSCLE CONTRACTION 27 60 1.79e-05 0.0001636
506 POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 27 60 1.79e-05 0.0001636
507 NEGATIVE REGULATION OF JNK CASCADE 18 33 1.784e-05 0.0001636
508 POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION 27 60 1.79e-05 0.0001636
509 EMBRYONIC EYE MORPHOGENESIS 18 33 1.784e-05 0.0001636
510 CELLULAR RESPONSE TO INSULIN STIMULUS 52 146 1.814e-05 0.0001655
511 MUSCLE CELL DEVELOPMENT 47 128 1.827e-05 0.0001663
512 REGULATION OF PROTEIN IMPORT 62 183 1.845e-05 0.0001676
513 REGULATION OF ORGAN GROWTH 31 73 1.856e-05 0.0001683
514 NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 45 121 1.88e-05 0.00017
515 REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 39 100 1.881e-05 0.00017
516 RESPONSE TO FATTY ACID 34 83 1.887e-05 0.0001702
517 CYCLIC NUCLEOTIDE METABOLIC PROCESS 26 57 1.896e-05 0.0001706
518 REGULATION OF SEQUESTERING OF CALCIUM ION 41 107 1.913e-05 0.0001719
519 RESPONSE TO REACTIVE OXYGEN SPECIES 64 191 2.023e-05 0.0001814
520 AXIS SPECIFICATION 36 90 2.031e-05 0.0001818
521 AGING 83 264 2.045e-05 0.0001826
522 CELLULAR RESPONSE TO FATTY ACID 24 51 2.068e-05 0.0001843
523 STEROID HORMONE MEDIATED SIGNALING PATHWAY 46 125 2.09e-05 0.0001859
524 EYELID DEVELOPMENT IN CAMERA TYPE EYE 10 13 2.1e-05 0.0001865
525 REGULATION OF MUSCLE SYSTEM PROCESS 65 195 2.11e-05 0.000187
526 POSITIVE REGULATION OF CATION TRANSMEMBRANE TRANSPORT 38 97 2.125e-05 0.0001879
527 EPITHELIAL CELL MORPHOGENESIS 21 42 2.13e-05 0.0001881
528 ENDOCHONDRAL BONE MORPHOGENESIS 22 45 2.146e-05 0.0001888
529 MESODERM DEVELOPMENT 44 118 2.146e-05 0.0001888
530 CELLULAR RESPONSE TO STEROID HORMONE STIMULUS 71 218 2.18e-05 0.0001914
531 REGULATION OF NEUROTRANSMITTER TRANSPORT 28 64 2.398e-05 0.0002101
532 ACTIN FILAMENT BASED PROCESS 129 450 2.405e-05 0.0002104
533 SKIN DEVELOPMENT 69 211 2.436e-05 0.0002127
534 REPRODUCTION 326 1297 2.536e-05 0.000221
535 REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT 27 61 2.584e-05 0.0002247
536 NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 46 126 2.641e-05 0.0002292
537 ION TRANSMEMBRANE TRANSPORT 217 822 2.662e-05 0.0002307
538 PEPTIDYL SERINE MODIFICATION 52 148 2.783e-05 0.0002407
539 SKIN EPIDERMIS DEVELOPMENT 30 71 2.828e-05 0.0002437
540 DICARBOXYLIC ACID TRANSPORT 30 71 2.828e-05 0.0002437
541 POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT 87 282 2.887e-05 0.0002483
542 EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 25 55 2.939e-05 0.0002523
543 RESPONSE TO AUDITORY STIMULUS 14 23 2.956e-05 0.0002524
544 REGULATION OF METANEPHROS DEVELOPMENT 14 23 2.956e-05 0.0002524
545 INNERVATION 14 23 2.956e-05 0.0002524
546 RESPONSE TO FLUID SHEAR STRESS 18 34 3.062e-05 0.00026
547 REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 71 220 3.056e-05 0.00026
548 HEART VALVE DEVELOPMENT 18 34 3.062e-05 0.00026
549 PRESYNAPTIC PROCESS INVOLVED IN SYNAPTIC TRANSMISSION 43 116 3.124e-05 0.0002648
550 RENAL SYSTEM PROCESS 39 102 3.199e-05 0.0002706
551 GLYCOSYLATION 83 267 3.222e-05 0.0002721
552 PEPTIDYL TYROSINE MODIFICATION 62 186 3.229e-05 0.0002722
553 REGULATION OF MEMBRANE LIPID DISTRIBUTION 19 37 3.244e-05 0.000273
554 PEPTIDYL THREONINE MODIFICATION 22 46 3.315e-05 0.0002784
555 REGULATION OF CANONICAL WNT SIGNALING PATHWAY 75 236 3.341e-05 0.0002801
556 CRANIAL NERVE DEVELOPMENT 21 43 3.358e-05 0.0002811
557 WNT SIGNALING PATHWAY 104 351 3.379e-05 0.0002823
558 CELLULAR RESPONSE TO RETINOIC ACID 28 65 3.389e-05 0.0002826
559 CARDIAC SEPTUM DEVELOPMENT 34 85 3.412e-05 0.000284
560 REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL 36 92 3.564e-05 0.0002961
561 REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 38 99 3.632e-05 0.0003002
562 REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 38 99 3.632e-05 0.0003002
563 LIPID PHOSPHORYLATION 38 99 3.632e-05 0.0003002
564 REGULATION OF VESICLE MEDIATED TRANSPORT 131 462 3.663e-05 0.0003022
565 LIPID LOCALIZATION 82 264 3.7e-05 0.0003047
566 RESPONSE TO CORTICOSTERONE 15 26 3.722e-05 0.000306
567 MAMMARY GLAND DEVELOPMENT 43 117 3.964e-05 0.0003253
568 EPIDERMIS DEVELOPMENT 79 253 4.154e-05 0.0003402
569 POSITIVE REGULATION OF LIPID METABOLIC PROCESS 46 128 4.161e-05 0.0003402
570 PERIPHERAL NERVOUS SYSTEM DEVELOPMENT 29 69 4.306e-05 0.0003515
571 NEURON CELL CELL ADHESION 11 16 4.33e-05 0.0003522
572 RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE 11 16 4.33e-05 0.0003522
573 POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 16 29 4.343e-05 0.0003527
574 POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 44 121 4.368e-05 0.000354
575 CHONDROCYTE DEVELOPMENT 13 21 4.469e-05 0.000361
576 SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT 13 21 4.469e-05 0.000361
577 REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE 24 53 4.556e-05 0.0003661
578 CELLULAR RESPONSE TO OXYGEN LEVELS 50 143 4.541e-05 0.0003661
579 MESONEPHRIC TUBULE MORPHOGENESIS 24 53 4.556e-05 0.0003661
580 RESPONSE TO RETINOIC ACID 40 107 4.655e-05 0.0003735
581 CELLULAR RESPONSE TO STRESS 384 1565 4.702e-05 0.0003765
582 HORMONE MEDIATED SIGNALING PATHWAY 54 158 4.724e-05 0.0003777
583 EMBRYONIC FORELIMB MORPHOGENESIS 17 32 4.799e-05 0.0003824
584 BICELLULAR TIGHT JUNCTION ASSEMBLY 17 32 4.799e-05 0.0003824
585 RESPONSE TO PROGESTERONE 23 50 4.811e-05 0.0003826
586 REGULATION OF MUSCLE CONTRACTION 51 147 4.845e-05 0.0003847
587 POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT 18 35 5.093e-05 0.0004023
588 NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 183 684 5.084e-05 0.0004023
589 RESPONSE TO IRON ION 18 35 5.093e-05 0.0004023
590 COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION 41 111 5.191e-05 0.0004094
591 NEGATIVE REGULATION OF STRESS ACTIVATED MAPK CASCADE 20 41 5.261e-05 0.0004135
592 NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 20 41 5.261e-05 0.0004135
593 CATION TRANSPORT 209 796 5.3e-05 0.0004158
594 CELLULAR LIPID METABOLIC PROCESS 236 913 5.346e-05 0.0004187
595 GASTRULATION 53 155 5.444e-05 0.0004257
596 DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS 69 216 5.629e-05 0.0004394
597 STEM CELL PROLIFERATION 26 60 5.659e-05 0.000441
598 DEVELOPMENTAL MATURATION 63 193 5.7e-05 0.0004435
599 CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS 14 24 5.749e-05 0.0004458
600 REGULATION OF ODONTOGENESIS 14 24 5.749e-05 0.0004458
601 REGULATION OF BINDING 86 283 5.851e-05 0.000453
602 REGULATION OF PROTEIN TARGETING 92 307 5.885e-05 0.0004549
603 REGULATION OF WOUND HEALING 45 126 5.963e-05 0.0004601
604 INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 10 14 5.985e-05 0.0004603
605 REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY 10 14 5.985e-05 0.0004603
606 REGULATION OF MUSCLE CELL DIFFERENTIATION 52 152 6.274e-05 0.0004818
607 REGULATION OF PEPTIDE SECRETION 67 209 6.339e-05 0.000486
608 REGULATION OF PROTEIN SECRETION 112 389 6.582e-05 0.0005037
609 ACTIVATION OF PHOSPHOLIPASE C ACTIVITY 15 27 6.781e-05 0.0005164
610 EXCITATORY POSTSYNAPTIC POTENTIAL 15 27 6.781e-05 0.0005164
611 CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS 15 27 6.781e-05 0.0005164
612 REGULATION OF NEUROTRANSMITTER SECRETION 23 51 7.064e-05 0.000537
613 CELL CELL JUNCTION ASSEMBLY 30 74 7.205e-05 0.0005469
614 POSITIVE REGULATION OF BINDING 45 127 7.413e-05 0.0005617
615 LIPID MODIFICATION 67 210 7.46e-05 0.0005644
616 MEMBRANE BIOGENESIS 16 30 7.53e-05 0.0005671
617 MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL 16 30 7.53e-05 0.0005671
618 RESPONSE TO HYDROGEN PEROXIDE 40 109 7.533e-05 0.0005671
619 REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 69 218 7.751e-05 0.0005826
620 REGULATION OF COAGULATION 34 88 7.839e-05 0.0005874
621 REGULATION OF CATION CHANNEL ACTIVITY 34 88 7.839e-05 0.0005874
622 TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 36 95 7.872e-05 0.0005889
623 MECHANOSENSORY BEHAVIOR 9 12 7.911e-05 0.0005909
624 EMBRYONIC DIGIT MORPHOGENESIS 26 61 7.943e-05 0.0005923
625 RETINA DEVELOPMENT IN CAMERA TYPE EYE 46 131 7.971e-05 0.0005934
626 NEURON RECOGNITION 17 33 8.003e-05 0.0005948
627 CATECHOLAMINE METABOLIC PROCESS 20 42 8.108e-05 0.0006007
628 CATECHOL CONTAINING COMPOUND METABOLIC PROCESS 20 42 8.108e-05 0.0006007
629 REGULATION OF AXON GUIDANCE 19 39 8.251e-05 0.0006084
630 ANATOMICAL STRUCTURE MATURATION 19 39 8.251e-05 0.0006084
631 GLANDULAR EPITHELIAL CELL DIFFERENTIATION 19 39 8.251e-05 0.0006084
632 AMINO ACID TRANSPORT 44 124 8.526e-05 0.0006277
633 CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS 13 22 8.862e-05 0.0006504
634 ACTIVIN RECEPTOR SIGNALING PATHWAY 13 22 8.862e-05 0.0006504
635 RESPONSE TO STARVATION 52 154 9.233e-05 0.0006765
636 CELL ACTIVATION 154 568 9.766e-05 0.0007145
637 REGULATION OF CALCIUM ION IMPORT 38 103 9.878e-05 0.0007215
638 CALCIUM ION IMPORT 27 65 9.956e-05 0.0007249
639 NEGATIVE REGULATION OF AXONOGENESIS 27 65 9.956e-05 0.0007249
640 SEGMENTATION 34 89 0.000102 0.0007413
641 ACTIVATION OF MAPKK ACTIVITY 23 52 0.0001021 0.0007413
642 CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION 55 166 0.0001048 0.0007598
643 STARTLE RESPONSE 14 25 0.0001059 0.0007662
644 REGULATION OF AMINE TRANSPORT 29 72 0.0001085 0.0007836
645 REGULATION OF CELL CYCLE 242 949 0.0001093 0.0007883
646 CARDIAC CELL DEVELOPMENT 22 49 0.0001095 0.0007889
647 CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS 160 595 0.0001124 0.000808
648 REGULATION OF SYNAPSE ASSEMBLY 31 79 0.0001138 0.0008169
649 LEUKOCYTE DIFFERENTIATION 87 292 0.0001149 0.0008237
650 RESPONSE TO INSULIN 65 205 0.000116 0.0008307
651 REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 15 28 0.0001183 0.0008453
652 RESPONSE TO METAL ION 97 333 0.0001229 0.0008771
653 POSITIVE REGULATION OF PROTEIN IMPORT 38 104 0.0001251 0.0008911
654 HINDLIMB MORPHOGENESIS 18 37 0.0001295 0.0009201
655 BRAIN MORPHOGENESIS 17 34 0.0001294 0.0009201
656 AXONAL FASCICULATION 12 20 0.0001362 0.0009649
657 NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION 12 20 0.0001362 0.0009649
658 CELL DEATH 253 1001 0.0001413 0.0009991
659 POSITIVE REGULATION OF PROTEIN BINDING 29 73 0.0001448 0.001023
660 BLASTODERM SEGMENTATION 10 15 0.0001462 0.001031
661 REGULATION OF LIPID METABOLIC PROCESS 84 282 0.0001505 0.001059
662 SYSTEM PROCESS 428 1785 0.0001532 0.001077
663 REGULATION OF ORGANIC ACID TRANSPORT 22 50 0.0001578 0.001106
664 POSITIVE REGULATION OF STEM CELL DIFFERENTIATION 22 50 0.0001578 0.001106
665 REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT 41 116 0.0001611 0.001126
666 REGULATION OF NUCLEOTIDE METABOLIC PROCESS 66 211 0.000161 0.001126
667 RESPONSE TO OXIDATIVE STRESS 101 352 0.000168 0.001172
668 ENSHEATHMENT OF NEURONS 34 91 0.0001692 0.001175
669 AXON ENSHEATHMENT 34 91 0.0001692 0.001175
670 CELLULAR MACROMOLECULE LOCALIZATION 305 1234 0.0001688 0.001175
671 AMMONIUM ION METABOLIC PROCESS 55 169 0.0001778 0.001233
672 BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS 20 44 0.0001812 0.001254
673 REPLACEMENT OSSIFICATION 14 26 0.000186 0.001282
674 REGULATION OF AMINO ACID TRANSPORT 14 26 0.000186 0.001282
675 ENDOCHONDRAL OSSIFICATION 14 26 0.000186 0.001282
676 REGULATION OF CELL SHAPE 47 139 0.0001885 0.001298
677 REGULATION OF MEMBRANE DEPOLARIZATION 19 41 0.0001911 0.001308
678 AORTA DEVELOPMENT 19 41 0.0001911 0.001308
679 PROSTATE GLAND DEVELOPMENT 19 41 0.0001911 0.001308
680 LUNG ALVEOLUS DEVELOPMENT 19 41 0.0001911 0.001308
681 NEGATIVE REGULATION OF HORMONE SECRETION 29 74 0.0001917 0.00131
682 RESPONSE TO PURINE CONTAINING COMPOUND 52 158 0.0001924 0.001313
683 REGULATED EXOCYTOSIS 69 224 0.0001927 0.001313
684 REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 15 29 0.0001984 0.001346
685 REGULATION OF PEPTIDE TRANSPORT 77 256 0.0001983 0.001346
686 EMBRYONIC HINDLIMB MORPHOGENESIS 15 29 0.0001984 0.001346
687 CELLULAR RESPONSE TO STARVATION 41 117 0.0001993 0.00135
688 ENDOCARDIAL CUSHION DEVELOPMENT 16 32 0.0002039 0.001367
689 POSITIVE REGULATION OF BMP SIGNALING PATHWAY 16 32 0.0002039 0.001367
690 POSITIVE REGULATION OF HEART CONTRACTION 17 35 0.0002036 0.001367
691 METANEPHRIC NEPHRON DEVELOPMENT 16 32 0.0002039 0.001367
692 RESPONSE TO MINERALOCORTICOID 17 35 0.0002036 0.001367
693 EMBRYONIC CAMERA TYPE EYE DEVELOPMENT 17 35 0.0002036 0.001367
694 ADIPOSE TISSUE DEVELOPMENT 16 32 0.0002039 0.001367
695 POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC 11 18 0.0002087 0.001395
696 PERICARDIUM DEVELOPMENT 11 18 0.0002087 0.001395
697 TYPE B PANCREATIC CELL DEVELOPMENT 9 13 0.0002099 0.001401
698 NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 65 209 0.0002154 0.001436
699 REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 66 213 0.0002176 0.001446
700 GLIAL CELL DIFFERENTIATION 46 136 0.0002176 0.001446
701 SENSORY PERCEPTION OF MECHANICAL STIMULUS 51 155 0.000222 0.001473
702 POSITIVE REGULATION OF SYNAPSE ASSEMBLY 25 61 0.0002292 0.001519
703 POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 44 129 0.0002387 0.00158
704 REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 21 48 0.0002437 0.001606
705 RESPONSE TO AXON INJURY 21 48 0.0002437 0.001606
706 COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT 21 48 0.0002437 0.001606
707 SENSORY PERCEPTION OF PAIN 29 75 0.0002517 0.001652
708 REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL 29 75 0.0002517 0.001652
709 POSITIVE REGULATION OF AUTOPHAGY 29 75 0.0002517 0.001652
710 NEGATIVE REGULATION OF WOUND HEALING 24 58 0.0002553 0.001673
711 METANEPHRIC NEPHRON MORPHOGENESIS 12 21 0.0002583 0.00169
712 POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 77 258 0.000259 0.001693
713 CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS 74 246 0.0002599 0.001696
714 HINDBRAIN DEVELOPMENT 46 137 0.000263 0.001714
715 GLYCEROLIPID METABOLIC PROCESS 101 356 0.0002639 0.001717
716 ACTIN FILAMENT BASED MOVEMENT 34 93 0.0002736 0.001778
717 ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY 47 141 0.0002744 0.001781
718 CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL 19 42 0.0002821 0.00182
719 DENDRITE MORPHOGENESIS 19 42 0.0002821 0.00182
720 REGULATION OF HEART GROWTH 19 42 0.0002821 0.00182
721 CALCIUM ION IMPORT INTO CYTOSOL 19 42 0.0002821 0.00182
722 REGULATION OF KIDNEY DEVELOPMENT 23 55 0.0002834 0.001826
723 REGULATION OF LEUKOCYTE APOPTOTIC PROCESS 30 79 0.0002875 0.00185
724 LEUKOCYTE MIGRATION 77 259 0.0002953 0.001898
725 ERBB2 SIGNALING PATHWAY 18 39 0.0002988 0.001915
726 LONG TERM SYNAPTIC POTENTIATION 18 39 0.0002988 0.001915
727 NEUROMUSCULAR PROCESS 35 97 0.0002999 0.00192
728 INTERACTION WITH HOST 45 134 0.0003036 0.00194
729 POSITIVE REGULATION OF REPRODUCTIVE PROCESS 22 52 0.0003132 0.001989
730 POSITIVE REGULATION OF HEART GROWTH 14 27 0.0003133 0.001989
731 REGULATION OF CATENIN IMPORT INTO NUCLEUS 14 27 0.0003133 0.001989
732 POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION 14 27 0.0003133 0.001989
733 SEMAPHORIN PLEXIN SIGNALING PATHWAY 17 36 0.0003121 0.001989
734 REGULATION OF SMAD PROTEIN IMPORT INTO NUCLEUS 10 16 0.0003178 0.002009
735 PARAXIAL MESODERM DEVELOPMENT 10 16 0.0003178 0.002009
736 STRIATUM DEVELOPMENT 10 16 0.0003178 0.002009
737 BROWN FAT CELL DIFFERENTIATION 15 30 0.0003216 0.002028
738 REGULATION OF MEMBRANE REPOLARIZATION 15 30 0.0003216 0.002028
739 REGENERATION 52 161 0.0003232 0.002033
740 NEGATIVE REGULATION OF OSSIFICATION 27 69 0.0003237 0.002033
741 RESPONSE TO ACTIVITY 27 69 0.0003237 0.002033
742 MULTICELLULAR ORGANISMAL HOMEOSTASIS 80 272 0.0003309 0.002075
743 PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS 21 49 0.0003444 0.002154
744 GLOMERULUS DEVELOPMENT 21 49 0.0003444 0.002154
745 MYELOID CELL DIFFERENTIATION 59 189 0.0003681 0.002299
746 ADULT LOCOMOTORY BEHAVIOR 30 80 0.0003704 0.00231
747 CARBOHYDRATE DERIVATIVE METABOLIC PROCESS 260 1047 0.0003732 0.002319
748 HIPPOCAMPUS DEVELOPMENT 28 73 0.0003732 0.002319
749 CELLULAR RESPONSE TO KETONE 28 73 0.0003732 0.002319
750 POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 52 162 0.000382 0.00237
751 MONOCARBOXYLIC ACID TRANSPORT 42 124 0.0003863 0.002393
752 EPITHELIAL TO MESENCHYMAL TRANSITION 23 56 0.000388 0.002401
753 REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY 11 19 0.0004033 0.002483
754 VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION 11 19 0.0004033 0.002483
755 NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY 11 19 0.0004033 0.002483
756 POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 11 19 0.0004033 0.002483
757 CEREBRAL CORTEX CELL MIGRATION 19 43 0.0004085 0.002511
758 REGULATION OF EXOCYTOSIS 58 186 0.0004235 0.002599
759 MUSCLE ORGAN MORPHOGENESIS 27 70 0.0004246 0.002603
760 HEMOSTASIS 89 311 0.0004349 0.002662
761 APICAL JUNCTION ASSEMBLY 18 40 0.0004393 0.002686
762 SINGLE ORGANISM CATABOLIC PROCESS 239 957 0.0004519 0.002759
763 ESTABLISHMENT OF CELL POLARITY 32 88 0.0004555 0.002778
764 MULTICELLULAR ORGANISM REPRODUCTION 196 768 0.0004571 0.002784
765 POSITIVE REGULATION OF ORGANELLE ORGANIZATION 151 573 0.0004628 0.002815
766 POSITIVE REGULATION OF CELL SUBSTRATE ADHESION 35 99 0.0004668 0.002836
767 POSITIVE REGULATION OF METANEPHROS DEVELOPMENT 9 14 0.0004799 0.002889
768 REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT 21 50 0.0004795 0.002889
769 VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY 9 14 0.0004799 0.002889
770 FACE DEVELOPMENT 21 50 0.0004795 0.002889
771 REGULATION OF GLOMERULUS DEVELOPMENT 9 14 0.0004799 0.002889
772 POSITIVE REGULATION OF FATTY ACID OXIDATION 9 14 0.0004799 0.002889
773 RESPONSE TO LAMINAR FLUID SHEAR STRESS 9 14 0.0004799 0.002889
774 POSITIVE REGULATION OF CELL GROWTH 48 148 0.0004833 0.002905
775 POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 16 34 0.0004902 0.002939
776 RESPONSE TO PROSTAGLANDIN 16 34 0.0004902 0.002939
777 MEMBRANE ASSEMBLY 13 25 0.0004955 0.002967
778 RESPONSE TO NUTRIENT 59 191 0.000497 0.002972
779 GLUTAMATE SECRETION 14 28 0.0005083 0.003009
780 POSITIVE REGULATION OF PURINE NUCLEOTIDE METABOLIC PROCESS 44 133 0.0005069 0.003009
781 PLASMA MEMBRANE ORGANIZATION 62 203 0.0005068 0.003009
782 REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION 14 28 0.0005083 0.003009
783 POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS 44 133 0.0005069 0.003009
784 REGULATION OF FATTY ACID OXIDATION 14 28 0.0005083 0.003009
785 METANEPHROS MORPHOGENESIS 14 28 0.0005083 0.003009
786 REGULATION OF SYNAPTIC VESICLE TRANSPORT 15 31 0.000505 0.003009
787 INORGANIC ION TRANSMEMBRANE TRANSPORT 153 583 0.0005187 0.003067
788 MYELOID LEUKOCYTE DIFFERENTIATION 34 96 0.0005381 0.003178
789 REGULATION OF CATABOLIC PROCESS 187 731 0.0005395 0.003182
790 REGULATION OF CARBOHYDRATE METABOLIC PROCESS 54 172 0.0005466 0.003219
791 CELLULAR RESPONSE TO OXIDATIVE STRESS 57 184 0.0005663 0.003331
792 VENTRICULAR SEPTUM DEVELOPMENT 22 54 0.0005888 0.003459
793 RESPONSE TO CALCIUM ION 39 115 0.0005952 0.003492
794 ORGANIC ACID METABOLIC PROCESS 237 953 0.000613 0.003592
795 CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES 36 104 0.000616 0.003605
796 EXOCYTOSIS 88 310 0.0006185 0.003615
797 CELLULAR RESPONSE TO HYDROGEN PEROXIDE 24 61 0.0006206 0.003619
798 POSITIVE REGULATION OF BLOOD CIRCULATION 33 93 0.0006203 0.003619
799 MULTI ORGANISM BEHAVIOR 28 75 0.0006219 0.003622
800 NEGATIVE REGULATION OF KIDNEY DEVELOPMENT 10 17 0.0006293 0.003632
801 BRANCH ELONGATION OF AN EPITHELIUM 10 17 0.0006293 0.003632
802 NEGATIVE REGULATION OF PLATELET ACTIVATION 10 17 0.0006293 0.003632
803 REGULATION OF CELL JUNCTION ASSEMBLY 26 68 0.0006299 0.003632
804 REGULATION OF ENERGY HOMEOSTASIS 10 17 0.0006293 0.003632
805 POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 10 17 0.0006293 0.003632
806 MAMMARY GLAND ALVEOLUS DEVELOPMENT 10 17 0.0006293 0.003632
807 MAMMARY GLAND LOBULE DEVELOPMENT 10 17 0.0006293 0.003632
808 NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION 18 41 0.0006335 0.003635
809 POSITIVE REGULATION OF KIDNEY DEVELOPMENT 18 41 0.0006335 0.003635
810 CELL SUBSTRATE JUNCTION ASSEMBLY 18 41 0.0006335 0.003635
811 GLUTAMATE RECEPTOR SIGNALING PATHWAY 18 41 0.0006335 0.003635
812 PHOSPHATIDYLINOSITOL METABOLIC PROCESS 59 193 0.000665 0.003811
813 NEGATIVE REGULATION OF ION TRANSPORT 42 127 0.0006764 0.003871
814 NEGATIVE REGULATION OF AXON EXTENSION 17 38 0.0006845 0.003894
815 BONE MINERALIZATION 17 38 0.0006845 0.003894
816 REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 17 38 0.0006845 0.003894
817 REGULATION OF RENAL SYSTEM PROCESS 17 38 0.0006845 0.003894
818 POSITIVE REGULATION OF ORGAN GROWTH 17 38 0.0006845 0.003894
819 RESPONSE TO AMINO ACID 38 112 0.0006877 0.003907
820 POSITIVE REGULATION OF VACUOLE ORGANIZATION 8 12 0.0007146 0.004011
821 NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE 8 12 0.0007146 0.004011
822 AXON EXTENSION INVOLVED IN AXON GUIDANCE 8 12 0.0007146 0.004011
823 REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS 8 12 0.0007146 0.004011
824 VASCULAR SMOOTH MUSCLE CONTRACTION 8 12 0.0007146 0.004011
825 REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY 8 12 0.0007146 0.004011
826 POSITIVE REGULATION OF CATENIN IMPORT INTO NUCLEUS 8 12 0.0007146 0.004011
827 ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY 8 12 0.0007146 0.004011
828 PROTEIN O LINKED GLYCOSYLATION 35 101 0.0007113 0.004011
829 REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY 8 12 0.0007146 0.004011
830 REGULATION OF CHEMOKINE PRODUCTION 25 65 0.0007178 0.004024
831 RESPONSE TO FIBROBLAST GROWTH FACTOR 39 116 0.0007208 0.004036
832 PARTURITION 11 20 0.0007298 0.004082
833 POSITIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS 20 48 0.0007336 0.004093
834 POSITIVE REGULATION OF RESPONSE TO NUTRIENT LEVELS 20 48 0.0007336 0.004093
835 RESPONSE TO ORGANOPHOSPHORUS 45 139 0.0007434 0.004142
836 REGULATION OF ORGAN FORMATION 15 32 0.0007708 0.00428
837 POSITIVE REGULATION OF AMINE TRANSPORT 15 32 0.0007708 0.00428
838 NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 15 32 0.0007708 0.00428
839 ADRENAL GLAND DEVELOPMENT 12 23 0.0007855 0.004351
840 BRANCHED CHAIN AMINO ACID METABOLIC PROCESS 12 23 0.0007855 0.004351
841 PROTEIN LOCALIZATION TO CELL PERIPHERY 48 151 0.000796 0.004404
842 REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC 14 29 0.0007974 0.004407
843 NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT 13 26 0.000805 0.004438
844 MESODERMAL CELL DIFFERENTIATION 13 26 0.000805 0.004438
845 LUNG MORPHOGENESIS 19 45 0.0008135 0.004474
846 SMOOTH MUSCLE CONTRACTION 19 45 0.0008135 0.004474
847 RESPONSE TO MOLECULE OF BACTERIAL ORIGIN 90 321 0.0008316 0.004568
848 REGULATION OF RECEPTOR ACTIVITY 39 117 0.0008694 0.00477
849 ENDOMEMBRANE SYSTEM ORGANIZATION 124 465 0.0008844 0.004847
850 REGULATION OF CARDIAC CONDUCTION 25 66 0.0009321 0.005102
851 CANONICAL WNT SIGNALING PATHWAY 33 95 0.000949 0.005189
852 TISSUE MIGRATION 30 84 0.0009506 0.005192
853 MESENCHYMAL TO EPITHELIAL TRANSITION 9 15 0.0009803 0.005329
854 OTIC VESICLE DEVELOPMENT 9 15 0.0009803 0.005329
855 CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS 9 15 0.0009803 0.005329
856 REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT 9 15 0.0009803 0.005329
857 RESPONSE TO CARBOHYDRATE 52 168 0.0009827 0.005329
858 POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 17 39 0.0009826 0.005329
859 NEGATIVE REGULATION OF PEPTIDE SECRETION 20 49 0.001002 0.005421
860 CELLULAR RESPONSE TO CALCIUM ION 20 49 0.001002 0.005421
861 VESICLE MEDIATED TRANSPORT 299 1239 0.00101 0.005458
862 REGULATION OF CIRCADIAN RHYTHM 35 103 0.001062 0.005733
863 NEUROMUSCULAR JUNCTION DEVELOPMENT 16 36 0.001067 0.00574
864 POSITIVE REGULATION OF AXON EXTENSION 16 36 0.001067 0.00574
865 LAMELLIPODIUM ORGANIZATION 16 36 0.001067 0.00574
866 CALCIUM ION REGULATED EXOCYTOSIS 29 81 0.001096 0.005889
867 OSTEOBLAST DIFFERENTIATION 41 126 0.001114 0.00598
868 INTRASPECIES INTERACTION BETWEEN ORGANISMS 19 46 0.001121 0.006003
869 SOCIAL BEHAVIOR 19 46 0.001121 0.006003
870 EMBRYONIC AXIS SPECIFICATION 15 33 0.001146 0.006123
871 EMBRYONIC DIGESTIVE TRACT DEVELOPMENT 15 33 0.001146 0.006123
872 VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 27 74 0.001157 0.006136
873 ORGAN MATURATION 10 18 0.001155 0.006136
874 GLANDULAR EPITHELIAL CELL DEVELOPMENT 10 18 0.001155 0.006136
875 CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS 10 18 0.001155 0.006136
876 ACTIN MEDIATED CELL CONTRACTION 27 74 0.001157 0.006136
877 INOSITOL PHOSPHATE MEDIATED SIGNALING 10 18 0.001155 0.006136
878 NEGATIVE REGULATION OF WNT SIGNALING PATHWAY 59 197 0.00116 0.006146
879 RESPONSE TO RADIATION 111 413 0.001193 0.006315
880 NEURON MATURATION 14 30 0.001214 0.006396
881 POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION 14 30 0.001214 0.006396
882 CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS 14 30 0.001214 0.006396
883 LAMELLIPODIUM ASSEMBLY 14 30 0.001214 0.006396
884 PLATELET ACTIVATION 45 142 0.001222 0.006431
885 PEPTIDYL TYROSINE DEPHOSPHORYLATION 34 100 0.001228 0.006458
886 NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION 18 43 0.001249 0.006545
887 POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL 11 21 0.001248 0.006545
888 REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS 11 21 0.001248 0.006545
889 REGULATION OF CARDIAC MUSCLE CELL CONTRACTION 13 27 0.001262 0.006581
890 HIPPO SIGNALING 13 27 0.001262 0.006581
891 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS 13 27 0.001262 0.006581
892 AXIS ELONGATION 13 27 0.001262 0.006581
893 REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY 31 89 0.001267 0.006602
894 REGULATION OF POSITIVE CHEMOTAXIS 12 24 0.001278 0.006637
895 CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION 12 24 0.001278 0.006637
896 IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY 12 24 0.001278 0.006637
897 LIPID METABOLIC PROCESS 280 1158 0.001282 0.006652
898 T CELL DIFFERENTIATION 40 123 0.001288 0.006672
899 POSITIVE REGULATION OF CELL ADHESION 102 376 0.001328 0.006871
900 REGULATION OF ADHERENS JUNCTION ORGANIZATION 20 50 0.00135 0.006966
901 STAT CASCADE 20 50 0.00135 0.006966
902 JAK STAT CASCADE 20 50 0.00135 0.006966
903 NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS 101 372 0.001356 0.006989
904 REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 17 40 0.001384 0.007101
905 POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 43 135 0.001384 0.007101
906 NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION 17 40 0.001384 0.007101
907 REGULATION OF FILOPODIUM ASSEMBLY 17 40 0.001384 0.007101
908 AMMONIUM TRANSPORT 22 57 0.001387 0.007107
909 MULTI ORGANISM REPRODUCTIVE PROCESS 220 891 0.001395 0.007142
910 AMIDE TRANSPORT 33 97 0.001421 0.007265
911 GLYCEROPHOSPHOLIPID METABOLIC PROCESS 83 297 0.001431 0.007309
912 POSITIVE REGULATION OF DNA REPLICATION 30 86 0.001465 0.007472
913 CILIUM MORPHOGENESIS 61 207 0.001497 0.00763
914 REGULATION OF VASCULOGENESIS 8 13 0.001522 0.007674
915 POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 8 13 0.001522 0.007674
916 PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 8 13 0.001522 0.007674
917 LIPOPROTEIN TRANSPORT 8 13 0.001522 0.007674
918 CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION 16 37 0.001524 0.007674
919 LEFT RIGHT AXIS SPECIFICATION 8 13 0.001522 0.007674
920 LIPOPROTEIN LOCALIZATION 8 13 0.001522 0.007674
921 MESENCHYMAL CELL PROLIFERATION 8 13 0.001522 0.007674
922 NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS 8 13 0.001522 0.007674
923 IMPORT INTO CELL 16 37 0.001524 0.007674
924 POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS 19 47 0.001523 0.007674
925 SYNAPTIC VESICLE CYCLE 31 90 0.001557 0.007833
926 REGULATION OF PHOSPHOLIPID METABOLIC PROCESS 23 61 0.001577 0.007922
927 TRANSMISSION OF NERVE IMPULSE 21 54 0.00158 0.00793
928 FOREBRAIN NEURON DEVELOPMENT 15 34 0.001664 0.008325
929 ORGAN FORMATION 15 34 0.001664 0.008325
930 NITROGEN COMPOUND TRANSPORT 132 507 0.001663 0.008325
931 HAIR CYCLE 29 83 0.001693 0.008453
932 MOLTING CYCLE 29 83 0.001693 0.008453
933 POSITIVE REGULATION OF MUSCLE CONTRACTION 18 44 0.001711 0.008534
934 REGULATION OF AUTOPHAGY 71 249 0.001723 0.008586
935 REGULATION OF PROTEIN KINASE B SIGNALING 39 121 0.001767 0.008793
936 RESPONSE TO TOXIC SUBSTANCE 69 241 0.001769 0.008795
937 MOVEMENT IN ENVIRONMENT OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 30 87 0.001801 0.00887
938 MULTICELLULAR ORGANISM AGING 14 31 0.001797 0.00887
939 ENTRY INTO CELL OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 30 87 0.001801 0.00887
940 VIRAL ENTRY INTO HOST CELL 30 87 0.001801 0.00887
941 ENTRY INTO OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 30 87 0.001801 0.00887
942 REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS 30 87 0.001801 0.00887
943 MOVEMENT IN HOST ENVIRONMENT 30 87 0.001801 0.00887
944 ENTRY INTO HOST 30 87 0.001801 0.00887
945 ENTRY INTO HOST CELL 30 87 0.001801 0.00887
946 NEGATIVE REGULATION OF MOLECULAR FUNCTION 261 1079 0.001807 0.008886
947 POSITIVE REGULATION OF TRANSPORTER ACTIVITY 27 76 0.001823 0.008948
948 MULTICELLULAR ORGANISM GROWTH 27 76 0.001823 0.008948
949 NEGATIVE REGULATION OF ADHERENS JUNCTION ORGANIZATION 9 16 0.001832 0.008955
950 POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT 9 16 0.001832 0.008955
951 NEGATIVE REGULATION OF STRESS FIBER ASSEMBLY 9 16 0.001832 0.008955
952 REGULATION OF DEVELOPMENTAL PIGMENTATION 9 16 0.001832 0.008955
953 REGULATION OF CAMP METABOLIC PROCESS 41 129 0.001845 0.009008
954 POSITIVE REGULATION OF CALCIUM ION TRANSPORT 35 106 0.001869 0.009108
955 REGULATION OF GLUCOSE METABOLIC PROCESS 35 106 0.001869 0.009108
956 CIRCADIAN RHYTHM 43 137 0.001906 0.009258
957 RESPONSE TO ALKALOID 43 137 0.001906 0.009258
958 ACTIVATION OF MAPK ACTIVITY 43 137 0.001906 0.009258
959 NEURONAL ACTION POTENTIAL 13 28 0.001914 0.009289
960 CARBOXYLIC ACID CATABOLIC PROCESS 60 205 0.001942 0.009402
961 ORGANIC ACID CATABOLIC PROCESS 60 205 0.001942 0.009402
962 ADENYLATE CYCLASE MODULATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY 45 145 0.001952 0.009441
963 TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER 47 153 0.001984 0.009584
964 DOPAMINE METABOLIC PROCESS 12 25 0.002 0.009606
965 REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION 12 25 0.002 0.009606
966 POSTSYNAPTIC MEMBRANE ORGANIZATION 12 25 0.002 0.009606
967 ENTEROENDOCRINE CELL DIFFERENTIATION 10 19 0.00199 0.009606
968 THYROID GLAND DEVELOPMENT 12 25 0.002 0.009606
969 REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY SARCOPLASMIC RETICULUM 12 25 0.002 0.009606
970 RESPIRATORY GASEOUS EXCHANGE 19 48 0.002039 0.009693
971 POSITIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY 19 48 0.002039 0.009693
972 ENDOCARDIAL CUSHION MORPHOGENESIS 11 22 0.002035 0.009693
973 POSITIVE REGULATION OF HEART RATE 11 22 0.002035 0.009693
974 REGULATION OF ENDOCRINE PROCESS 19 48 0.002039 0.009693
975 REGULATION OF SMOOTHENED SIGNALING PATHWAY 23 62 0.002024 0.009693
976 SYNAPTIC TRANSMISSION GLUTAMATERGIC 11 22 0.002035 0.009693
977 AORTA MORPHOGENESIS 11 22 0.002035 0.009693
978 SUBPALLIUM DEVELOPMENT 11 22 0.002035 0.009693
979 REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT 19 48 0.002039 0.009693
980 NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION 21 55 0.002066 0.00981
981 NEGATIVE REGULATION OF MAP KINASE ACTIVITY 26 73 0.002106 0.009979
982 PANCREAS DEVELOPMENT 26 73 0.002106 0.009979
NumGOOverlapSizeP ValueAdj. P Value
1 RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING 223 629 1.351e-18 7.026e-16
2 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 137 328 1.513e-18 7.026e-16
3 NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY 366 1199 3.692e-17 1.143e-14
4 RECEPTOR BINDING 424 1476 7.157e-15 1.662e-12
5 REGULATORY REGION NUCLEIC ACID BINDING 260 818 1.152e-14 2.141e-12
6 ENZYME BINDING 482 1737 5.447e-14 8.434e-12
7 PROTEIN KINASE ACTIVITY 211 640 7.386e-14 9.803e-12
8 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING 121 315 2.19e-13 2.544e-11
9 DOUBLE STRANDED DNA BINDING 240 764 5.131e-13 5.296e-11
10 MOLECULAR FUNCTION REGULATOR 385 1353 6.265e-13 5.82e-11
11 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 93 226 1.368e-12 1.155e-10
12 KINASE ACTIVITY 257 842 2.505e-12 1.94e-10
13 SEQUENCE SPECIFIC DNA BINDING 303 1037 8.409e-12 6.009e-10
14 CORE PROMOTER PROXIMAL REGION DNA BINDING 132 371 1.168e-11 7.752e-10
15 RIBONUCLEOTIDE BINDING 496 1860 2.428e-11 1.504e-09
16 GROWTH FACTOR BINDING 58 123 3.658e-11 2.124e-09
17 ADENYL NUCLEOTIDE BINDING 413 1514 5.764e-11 3.15e-09
18 GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 110 303 1.526e-10 7.875e-09
19 CALCIUM ION BINDING 213 697 1.773e-10 8.67e-09
20 PROTEIN DOMAIN SPECIFIC BINDING 194 624 2.44e-10 1.133e-08
21 PROTEIN SERINE THREONINE KINASE ACTIVITY 147 445 4.016e-10 1.777e-08
22 MACROMOLECULAR COMPLEX BINDING 381 1399 4.325e-10 1.827e-08
23 RECEPTOR SIGNALING PROTEIN ACTIVITY 71 172 5.022e-10 2.028e-08
24 RAS GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 87 228 7.401e-10 2.865e-08
25 NUCLEOSIDE TRIPHOSPHATASE REGULATOR ACTIVITY 114 329 1.743e-09 6.478e-08
26 TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS 280 992 2.66e-09 9.506e-08
27 IDENTICAL PROTEIN BINDING 330 1209 5.413e-09 1.863e-07
28 TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY 40 81 7.362e-09 2.442e-07
29 ENZYME ACTIVATOR ACTIVITY 149 471 8.421e-09 2.698e-07
30 KINASE BINDING 182 606 1.598e-08 4.947e-07
31 CYTOSKELETAL PROTEIN BINDING 234 819 1.856e-08 5.563e-07
32 LIPID BINDING 191 657 1.004e-07 2.915e-06
33 GLYCOSAMINOGLYCAN BINDING 74 205 1.897e-07 5.342e-06
34 CELL ADHESION MOLECULE BINDING 68 186 3.398e-07 9.285e-06
35 SULFUR COMPOUND BINDING 81 234 3.927e-07 1.042e-05
36 ENZYME REGULATOR ACTIVITY 260 959 4.464e-07 1.152e-05
37 PROTEIN COMPLEX BINDING 253 935 7.564e-07 1.899e-05
38 CHROMATIN BINDING 132 435 7.955e-07 1.945e-05
39 PROTEIN HOMODIMERIZATION ACTIVITY 202 722 8.964e-07 2.082e-05
40 PDZ DOMAIN BINDING 39 90 8.833e-07 2.082e-05
41 PROTEIN DIMERIZATION ACTIVITY 302 1149 1.075e-06 2.436e-05
42 PROTEIN KINASE A BINDING 23 42 1.122e-06 2.481e-05
43 SMAD BINDING 33 72 1.31e-06 2.831e-05
44 PHOSPHOLIPID BINDING 112 360 1.436e-06 3.031e-05
45 HEPARIN BINDING 58 157 1.632e-06 3.369e-05
46 TRANSCRIPTION FACTOR BINDING 152 524 2.291e-06 4.626e-05
47 GROWTH FACTOR ACTIVITY 58 160 3.274e-06 6.471e-05
48 TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING 25 50 3.559e-06 6.889e-05
49 TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 42 105 4.313e-06 8.178e-05
50 PHOSPHOLIPID TRANSLOCATING ATPASE ACTIVITY 12 16 4.533e-06 8.421e-05
51 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING 50 133 4.671e-06 8.509e-05
52 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 31 70 6.595e-06 0.0001164
53 ZINC ION BINDING 298 1155 6.641e-06 0.0001164
54 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY 29 64 7.488e-06 0.0001288
55 RHO GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 33 77 7.975e-06 0.0001347
56 ACTIN BINDING 117 393 8.883e-06 0.0001474
57 TRANSITION METAL ION BINDING 352 1400 1.159e-05 0.0001857
58 TRANSMEMBRANE TRANSPORTER ACTIVITY 260 997 1.141e-05 0.0001857
59 METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY 122 417 1.43e-05 0.0002252
60 RECEPTOR SERINE THREONINE KINASE BINDING 11 15 1.665e-05 0.0002578
61 ATPASE ACTIVITY COUPLED TO MOVEMENT OF SUBSTANCES 45 121 1.88e-05 0.0002863
62 VOLTAGE GATED ION CHANNEL ACTIVITY 63 190 3.359e-05 0.0004998
63 COLLAGEN BINDING 28 65 3.389e-05 0.0004998
64 RECEPTOR SIGNALING PROTEIN SERINE THREONINE KINASE ACTIVITY 36 92 3.564e-05 0.0005173
65 TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING 57 168 3.747e-05 0.0005355
66 CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 46 128 4.161e-05 0.0005857
67 TRANSFORMING GROWTH FACTOR BETA BINDING 11 16 4.33e-05 0.0006004
68 PASSIVE TRANSMEMBRANE TRANSPORTER ACTIVITY 131 464 4.555e-05 0.0006223
69 PHOSPHATIDYLINOSITOL BINDING 65 200 5.096e-05 0.0006861
70 GLUCOCORTICOID RECEPTOR BINDING 10 14 5.985e-05 0.000783
71 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER SEQUENCE SPECIFIC 10 14 5.985e-05 0.000783
72 PROTEIN TYROSINE KINASE BINDING 24 54 6.608e-05 0.0008527
73 CHEMOREPELLENT ACTIVITY 15 27 6.781e-05 0.0008629
74 TRANSCRIPTION FACTOR ACTIVITY DIRECT LIGAND REGULATED SEQUENCE SPECIFIC DNA BINDING 22 48 7.482e-05 0.0009334
75 GATED CHANNEL ACTIVITY 96 325 7.535e-05 0.0009334
76 PROTEIN TYROSINE KINASE ACTIVITY 58 176 8.176e-05 0.0009994
77 TRANSPORTER ACTIVITY 317 1276 8.446e-05 0.001019
78 TRANSCRIPTION FACTOR ACTIVITY PROTEIN BINDING 159 588 8.757e-05 0.001043
79 TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE ACTIVITY 11 17 9.976e-05 0.001173
80 GROWTH FACTOR RECEPTOR BINDING 45 129 0.0001131 0.001314
81 ION CHANNEL BINDING 40 111 0.0001194 0.001369
82 STEROID HORMONE RECEPTOR ACTIVITY 25 59 0.0001215 0.001376
83 DIVALENT INORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY 55 167 0.0001254 0.001386
84 HYDROLASE ACTIVITY ACTING ON ACID ANHYDRIDES 212 820 0.0001251 0.001386
85 GLYCOPROTEIN BINDING 37 101 0.0001434 0.001567
86 PROTEIN KINASE A CATALYTIC SUBUNIT BINDING 10 15 0.0001462 0.00158
87 CATION CHANNEL ACTIVITY 88 298 0.0001481 0.001581
88 SH3 DOMAIN BINDING 41 116 0.0001611 0.001701
89 ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY 102 356 0.000166 0.001733
90 ACTIVATING TRANSCRIPTION FACTOR BINDING 24 57 0.0001856 0.001916
91 INSULIN RECEPTOR BINDING 16 32 0.0002039 0.002081
92 KINASE REGULATOR ACTIVITY 59 186 0.0002305 0.002327
93 PHOSPHOLIPID TRANSPORTER ACTIVITY 21 48 0.0002437 0.002435
94 SCAFFOLD PROTEIN BINDING 20 45 0.0002634 0.002603
95 TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING 32 86 0.000283 0.002739
96 RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING 37 104 0.0002831 0.002739
97 PROTEIN KINASE A REGULATORY SUBUNIT BINDING 10 16 0.0003178 0.003013
98 METALLOPEPTIDASE ACTIVITY 59 188 0.0003156 0.003013
99 EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT 29 76 0.0003277 0.003044
100 CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING 36 101 0.0003259 0.003044
101 ATPASE ACTIVITY COUPLED 90 313 0.0003411 0.003137
102 PHOSPHATASE BINDING 52 162 0.000382 0.003479
103 X1 PHOSPHATIDYLINOSITOL BINDING 11 19 0.0004033 0.003638
104 X1 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 19 43 0.0004085 0.003649
105 SEMAPHORIN RECEPTOR BINDING 12 22 0.000462 0.004087
106 SIGNALING ADAPTOR ACTIVITY 28 74 0.0004837 0.004239
107 CYTOKINE BINDING 33 92 0.0004973 0.004278
108 CORE PROMOTER BINDING 49 152 0.0004962 0.004278
109 MAGNESIUM ION BINDING 61 199 0.0005042 0.004293
110 HISTONE ACETYLTRANSFERASE BINDING 14 28 0.0005083 0.004293
111 ATPASE ACTIVITY 116 427 0.000615 0.005147
112 PHOSPHATIDYLINOSITOL PHOSPHATE BINDING 39 116 0.0007208 0.005859
113 HORMONE BINDING 25 65 0.0007178 0.005859
114 VOLTAGE GATED SODIUM CHANNEL ACTIVITY 11 20 0.0007298 0.005859
115 GTPASE BINDING 84 295 0.0007315 0.005859
116 EXTRACELLULAR GLUTAMATE GATED ION CHANNEL ACTIVITY 11 20 0.0007298 0.005859
117 HISTONE DEACETYLASE BINDING 36 105 0.000754 0.005936
118 INTEGRIN BINDING 36 105 0.000754 0.005936
119 KINASE ACTIVATOR ACTIVITY 24 62 0.000817 0.006378
120 PHOSPHORIC ESTER HYDROLASE ACTIVITY 101 368 0.0009231 0.007146
121 X3 5 CYCLIC AMP PHOSPHODIESTERASE ACTIVITY 9 15 0.0009803 0.007404
122 ICOSANOID RECEPTOR ACTIVITY 9 15 0.0009803 0.007404
123 PLATELET DERIVED GROWTH FACTOR RECEPTOR BINDING 9 15 0.0009803 0.007404
124 TUBULIN BINDING 78 273 0.0009945 0.007451
125 PROTEIN TYROSINE PHOSPHATASE ACTIVITY 35 103 0.001062 0.007893
126 SYNTAXIN 1 BINDING 10 18 0.001155 0.008384
127 BINDING BRIDGING 53 173 0.001147 0.008384
128 HMG BOX DOMAIN BINDING 10 18 0.001155 0.008384
129 ORGANIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY 45 142 0.001222 0.008799
130 TRANSCRIPTION COFACTOR BINDING 12 24 0.001278 0.009133
131 CHANNEL REGULATOR ACTIVITY 42 131 0.001355 0.009609
NumGOOverlapSizeP ValueAdj. P Value
1 SYNAPSE 282 754 1.995e-27 7.987e-25
2 CELL PROJECTION 552 1786 2.735e-27 7.987e-25
3 CELL JUNCTION 384 1151 1.375e-25 2.676e-23
4 NEURON PART 409 1265 3.218e-24 4.698e-22
5 NEURON PROJECTION 322 942 1.912e-23 2.234e-21
6 SYNAPSE PART 222 610 4.45e-20 4.331e-18
7 MEMBRANE REGION 360 1134 7.065e-20 5.894e-18
8 PROTEINACEOUS EXTRACELLULAR MATRIX 145 356 2.267e-18 1.655e-16
9 PLASMA MEMBRANE REGION 301 929 4.135e-18 2.683e-16
10 SOMATODENDRITIC COMPARTMENT 227 650 5.079e-18 2.966e-16
11 INTRINSIC COMPONENT OF PLASMA MEMBRANE 480 1649 6.178e-18 3.28e-16
12 EXTRACELLULAR MATRIX 163 426 2.251e-17 1.095e-15
13 POSTSYNAPSE 146 378 4.191e-16 1.883e-14
14 CELL PROJECTION PART 296 946 1.487e-15 6.203e-14
15 EXTRACELLULAR MATRIX COMPONENT 64 125 2.921e-14 1.137e-12
16 DENDRITE 161 451 4.622e-14 1.687e-12
17 EXCITATORY SYNAPSE 85 197 5.739e-13 1.972e-11
18 CELL BODY 168 494 1.538e-12 4.989e-11
19 AXON 147 418 2.219e-12 6.82e-11
20 CELL CELL JUNCTION 136 383 6.716e-12 1.961e-10
21 CELL LEADING EDGE 126 350 1.384e-11 3.849e-10
22 ANCHORING JUNCTION 162 489 4e-11 1.062e-09
23 BASEMENT MEMBRANE 46 93 5.254e-10 1.334e-08
24 MEMBRANE MICRODOMAIN 102 288 3.291e-09 8.009e-08
25 SYNAPTIC MEMBRANE 94 261 5.136e-09 1.2e-07
26 APICAL PART OF CELL 121 361 5.393e-09 1.211e-07
27 GOLGI APPARATUS 385 1445 6.043e-09 1.307e-07
28 APICAL PLASMA MEMBRANE 102 292 7.596e-09 1.584e-07
29 T TUBULE 27 45 9.189e-09 1.85e-07
30 CELL SUBSTRATE JUNCTION 129 398 1.707e-08 3.322e-07
31 RECEPTOR COMPLEX 110 327 2.116e-08 3.987e-07
32 APICAL JUNCTION COMPLEX 54 128 2.35e-08 4.289e-07
33 CYTOPLASMIC REGION 97 287 1.096e-07 1.94e-06
34 PLASMA MEMBRANE PROTEIN COMPLEX 154 510 1.39e-07 2.388e-06
35 AXON PART 78 219 1.705e-07 2.845e-06
36 SARCOLEMMA 51 125 2.051e-07 3.291e-06
37 PLASMA MEMBRANE RAFT 39 86 2.085e-07 3.291e-06
38 ACTIN BASED CELL PROJECTION 67 181 2.428e-07 3.732e-06
39 CELL SURFACE 213 757 2.873e-07 4.303e-06
40 FILOPODIUM 41 94 3.781e-07 5.52e-06
41 PERINUCLEAR REGION OF CYTOPLASM 184 642 4.958e-07 7.062e-06
42 PRESYNAPSE 92 283 1.586e-06 2.206e-05
43 ENDOPLASMIC RETICULUM 410 1631 2.143e-06 2.911e-05
44 SITE OF POLARIZED GROWTH 55 149 3.083e-06 4.086e-05
45 NEURON SPINE 47 121 3.148e-06 4.086e-05
46 CELL CORTEX 79 238 3.488e-06 4.428e-05
47 NEURON PROJECTION MEMBRANE 20 36 4.181e-06 5.195e-05
48 CATION CHANNEL COMPLEX 59 167 6.869e-06 8.357e-05
49 PRESYNAPTIC ACTIVE ZONE 17 29 8.342e-06 9.942e-05
50 NEURONAL POSTSYNAPTIC DENSITY 25 53 1.328e-05 0.0001551
51 POSTSYNAPTIC MEMBRANE 68 205 1.653e-05 0.0001893
52 LAMELLIPODIUM 59 172 1.913e-05 0.0002148
53 NEURON PROJECTION TERMINUS 47 129 2.305e-05 0.000254
54 GLYCOPROTEIN COMPLEX 13 21 4.469e-05 0.0004833
55 BASOLATERAL PLASMA MEMBRANE 68 211 4.667e-05 0.0004956
56 INTRACELLULAR VESICLE 315 1259 5.063e-05 0.000528
57 VOLTAGE GATED SODIUM CHANNEL COMPLEX 10 14 5.985e-05 0.0006132
58 GOLGI APPARATUS PART 231 893 6.09e-05 0.0006132
59 NEUROMUSCULAR JUNCTION 24 54 6.608e-05 0.0006541
60 PLASMA MEMBRANE RECEPTOR COMPLEX 58 175 6.837e-05 0.000663
61 LEADING EDGE MEMBRANE 47 134 6.925e-05 0.000663
62 CELL PROJECTION MEMBRANE 89 298 8.795e-05 0.0008284
63 I BAND 43 121 9.806e-05 0.000909
64 ACTIN CYTOSKELETON 124 444 0.0001193 0.001088
65 COMPLEX OF COLLAGEN TRIMERS 13 23 0.0001654 0.001442
66 CONTRACTILE FIBER 66 211 0.000161 0.001442
67 ACTIN FILAMENT 28 70 0.000163 0.001442
68 PLATELET ALPHA GRANULE 29 75 0.0002517 0.002162
69 CYTOSKELETON 463 1967 0.0004506 0.003814
70 VACUOLE 289 1180 0.0004672 0.003898
71 TRANSPORTER COMPLEX 91 321 0.0005301 0.00436
72 CELL CELL ADHERENS JUNCTION 22 54 0.0005888 0.004776
73 SODIUM CHANNEL COMPLEX 10 17 0.0006293 0.005035
74 PERIKARYON 37 108 0.0006527 0.005151
75 GOLGI MEMBRANE 179 703 0.0008851 0.006892
76 COMPACT MYELIN 9 15 0.0009803 0.007533
77 ENDOPLASMIC RETICULUM PART 282 1163 0.001036 0.007759
78 COLLAGEN TRIMER 31 88 0.001025 0.007759
79 COATED PIT 25 67 0.0012 0.008868
80 CELL CELL CONTACT ZONE 24 64 0.001376 0.009858
81 VOLTAGE GATED CALCIUM CHANNEL COMPLEX 17 40 0.001384 0.009858
82 TERMINAL BOUTON 24 64 0.001376 0.009858

Over-represented Pathway

NumPathwayPathviewOverlapSizeP ValueAdj. P Value
1 MAPK_signaling_pathway_hsa04010 111 295 9.876e-12 5.136e-10
2 TGF_beta_signaling_pathway_hsa04350 42 84 1.926e-09 5.008e-08
3 Hippo_signaling_pathway_hsa04390 63 154 7.083e-09 7.139e-08
4 Focal_adhesion_hsa04510 76 199 8.204e-09 7.139e-08
5 Rap1_signaling_pathway_hsa04015 78 206 8.213e-09 7.139e-08
6 PI3K_Akt_signaling_pathway_hsa04151 118 352 8.237e-09 7.139e-08
7 Ras_signaling_pathway_hsa04014 80 232 5.517e-07 3.898e-06
8 Signaling_pathways_regulating_pluripotency_of_stem_cells_hsa04550 54 139 5.997e-07 3.898e-06
9 cAMP_signaling_pathway_hsa04024 70 198 9.775e-07 5.648e-06
10 cGMP_PKG_signaling_pathway_hsa04022 60 163 1.251e-06 6.377e-06
11 Gap_junction_hsa04540 38 88 1.349e-06 6.377e-06
12 FoxO_signaling_pathway_hsa04068 51 132 1.475e-06 6.394e-06
13 Calcium_signaling_pathway_hsa04020 62 182 1.522e-05 6.088e-05
14 Adherens_junction_hsa04520 30 72 3.9e-05 0.0001368
15 Phospholipase_D_signaling_pathway_hsa04072 51 146 3.945e-05 0.0001368
16 Regulation_of_actin_cytoskeleton_hsa04810 65 208 0.0001851 0.0006016
17 ECM_receptor_interaction_hsa04512 31 82 0.0002521 0.0007597
18 Apelin_signaling_pathway_hsa04371 46 137 0.000263 0.0007597
19 Wnt_signaling_pathway_hsa04310 48 146 0.0003412 0.0009337
20 ABC_transporters_hsa02010 19 45 0.0008135 0.002115
21 mTOR_signaling_pathway_hsa04150 47 151 0.00147 0.003641
22 p53_signaling_pathway_hsa04115 24 68 0.00351 0.008297
23 Neuroactive_ligand_receptor_interaction_hsa04080 76 278 0.004094 0.008961
24 Phosphatidylinositol_signaling_system_hsa04070 32 99 0.004136 0.008961
25 ErbB_signaling_pathway_hsa04012 28 85 0.005243 0.01091
26 Tight_junction_hsa04530 49 170 0.006538 0.01308
27 Endocytosis_hsa04144 66 244 0.009081 0.01749
28 Cytokine_cytokine_receptor_interaction_hsa04060 72 270 0.009496 0.01764
29 AMPK_signaling_pathway_hsa04152 36 121 0.01071 0.01921
30 Oocyte_meiosis_hsa04114 36 124 0.01587 0.02751
31 HIF_1_signaling_pathway_hsa04066 30 100 0.01656 0.02778
32 Cellular_senescence_hsa04218 44 160 0.02191 0.03561
33 Hippo_signaling_pathway_multiple_species_hsa04392 11 29 0.02419 0.03812
34 Cell_adhesion_molecules_.CAMs._hsa04514 40 145 0.0265 0.03994
35 Jak_STAT_signaling_pathway_hsa04630 44 162 0.02688 0.03994
36 Sphingolipid_signaling_pathway_hsa04071 33 118 0.03409 0.04924
37 TNF_signaling_pathway_hsa04668 30 108 0.04538 0.06377
38 Autophagy_animal_hsa04140 34 128 0.06208 0.08294
39 Mitophagy_animal_hsa04137 19 65 0.06246 0.08294
40 Cell_cycle_hsa04110 33 124 0.0638 0.08294
41 Peroxisome_hsa04146 23 83 0.07438 0.09433
42 Apoptosis_multiple_species_hsa04215 10 33 0.1242 0.1538
43 Apoptosis_hsa04210 34 138 0.1425 0.1723
44 Hedgehog_signaling_pathway_hsa04340 13 47 0.1543 0.1823
45 Notch_signaling_pathway_hsa04330 11 48 0.4006 0.4629
46 Ferroptosis_hsa04216 9 40 0.4444 0.5024
47 VEGF_signaling_pathway_hsa04370 12 59 0.5714 0.6322
48 Autophagy_other_hsa04136 6 32 0.6708 0.7267
49 Phagosome_hsa04145 27 152 0.8335 0.8845
50 Necroptosis_hsa04217 27 164 0.9242 0.9611
51 NF_kappa_B_signaling_pathway_hsa04064 14 95 0.9436 0.9621
52 Lysosome_hsa04142 18 123 0.9646 0.9646

Quest ID: 1951154b9359077ffe8ffd16988acfb3